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                                                INTRODUCTION 
             “                              
                              ”[1] 
-        -   . 950 
“HEALTH IS NOT VALID TILL SICKNESS COMES” 
              Tuberculosis is a communicable chronic granulomatous disease caused by 
Mycobacterium tuberculosis. It usually involves the lungs but may affect any organ or 
tissue in the body, but the pulmonary system is the primary target for Mycobacterium 
tuberculosis. 
Anti-tuberculosis agents are drugs with different mechanism of action having 
activity against Mycobacterium tuberculosis. 
Tuberculosis accounts for millions of death worldwide every year. Diverse 
survival strategies adopted by Mycobacterium tuberculosis have substantially 
hindered the existing anti-TB regimen thereby leading to Multi- Drug Resistant 
(MDR) and Extremely Drug Resistant (XDR) strains of tuberculosis.
[1] 
           “THE ART OF MEDICINE CONSISTS IN AMUSING THE PATIENT 
             WHILE NATURE CURES THE DISEASE.” 
Keeping the aforesaid facts in view, medicinal plants may represent a potential 
option to combat the threat of Tuberculosis. The trial drug, an herbal formulation, 
“THIRIJADHATHI MATHIRAI” will be a new and effective alternative medicine 
for tuberculosis.   
The respiratory system is an outgrowth from the ventral wall of the foregut.
[2]
 
The lungs are a pair of spongy, air filled, respiratory organ situated in the thoracic 
cavity. The lungs are lined by epithelial cells, which help trap particles and prevent 
infection from reaching the lungs. 
            Important functions of the lungs are, 
1. Gaseous exchange 
2. Removal of waste and toxins 
3. Defence against infection and harmful substance 
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             The airways are the central component of the lung, organised in a bronchial 
network. It is an immunological interface under constant assault by inhaled 
particulates and pathogens.
[1]
  
                            “NATURAL FORCES WITHIN US ARE  
                   THE TRUE HEALERS OF DISEASE” 
- HIPPOCRATES 
Lung diseases, particularly tuberculosis has been known to mankind since 
ancient times. 
In ancient times, Consumption, Phthisis and The White plaque are the terms 
used to refer tuberculosis. The evidence of first tuberculosis infection happened about 
9000 years ago. It spread to humans along trade routes and through domesticated 
animals. Mycobacterium bovis  is disease causing organism that spread through 
animal domestication. 
In the Neolithic era (9000 years ago), evidence of spinal tuberculosis is seen. 
Signs of the disease have also been found in Egyptian mummies dated between 3000 
and 2400 B.C. 
  The first reference to tuberculosis in Non-European civilization is found in the 
Vedas. 
Rigveda (1500 B.C) calls the disease YAKSHMA. The Atharva veda calls it 
BALASA. The SUSHRUTA SAMHITA, written around 600 B.C, recommends that 
the disease be treated with breast milk, various meats, alcohol and rest. The 
YAJURVEDA advises sufferers to move to higher altitudes. 
        Hippocrates, in the book  “Of the epidemics”, describes the characteristics of the 
disease, 
 Fever 
 Colourless urine 
 Cough with thick sputum 
 Loss of thirst and appetite 
         They believed Phthisis to be hereditary but Aristotle disagreed and believed that 
the disease was a contagious. 
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         In middle ages it was believed that royal touch of the Sovereign of England of 
France could cure disease due to the divine right of Sovereign. It is known as the 
“KING’S EVIL”. 
        Girdamo Francastro is the first person to propose that phthisis was transmitted by 
an invisible virus. The incidence of tuberculosis grew progressively during the middle 
ages and Renaissance, displacing leprosy peaking between the 18
th
 and 19
th
 century. 
        In 1882, Prussian physician Robert Koch utilized a new staining method and 
applied it to the sputum of tuberculosis patients, revealing for the first time the 
causative agent of the disease, Mycobacterium tuberculosis.
[3] 
        The first immunization against tuberculosis was developed from attenuated 
bovine strain tuberculosis by Albert Calmette and Camille Guerin in 1906. It was 
called “BCG” (Baccille Calmette- Guerin). The BCG vaccine was first used on 
humans in 1921 in France. 
        In 1944 Albert Schatz, Elizabeth Bugie and Selman Waksman isolated 
streptomycin from Streptomyces griseus. It was the first effective antibiotic against 
M. tuberculosis. In 1982, on the 100
th anniversary of Robert Koch’s presentation the 
International Union Against Tuberculosis and Lung Disease (IUATLD) proposed that 
24 March as official TB day.
 
       Mycobacteria are slender rods, fungus like bacteria, aerobic, non-motile, non-
capsulated, gram positive and acid fast bacilli. 
      Acid fast bacilli have waxy substance called mycolic acid in their cell walls which 
make them impermeable to many staining procedures. They are able to resist 
decolourization with acid alcohol. The stain used for acid fast bacilli is carbol fushsin 
by the Ziehl- Neelsen method or by fluorescent dyes. 
      Mode of transmission of this bacilli occurs through inhalation, ingestion, 
inoculation and transplacental route. Primary and secondary tuberculosis are the types 
of tuberculosis.
[4] 
      Primary tuberculosis is the initial infection of the tubercle bacilli in a host. The 
bacilli engulfed by alveolar macrophages multiply and gives rise to a subpleural focus 
of tuberculous pneumonia, commonly located in the lower lobe or the lower part of 
the upper lobe (Ghon’s focus). The hilar lymph nodes are involved. 
      The Ghon’s focus together with the enlarged hilar lymph node constitutes the 
primary complex. This occurs about 3-8 weeks from the time of infection and is 
associated with the development of tuberculin hypersensitivity. 
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         The secondary tuberculosis is due to reactivation of latent infection. It affects 
mainly the upper lobes of the lungs. The clinical features includes, referable to lungs, 
 Productive cough may be with haemoptysis 
 Pleural effusion 
 Dyspnoea 
 Orthopnoea etc,. 
         Systemic features, 
 Fever 
 Night sweats 
 Fatigue 
 Loss of weight and appetite 
      The diagnosis test includes, 
 Positive Mantoux skin test 
 Positive sputum for AFB 
 Complete haemogram 
 Chest x-ray 
 Fine needle aspiration cytology of enlarged peripheral lymph 
node.
[5]
 
Tuberculosis is the ninth leading cause of death worldwide. In 2017 it is 
estimated that1.3 million people were died from TB and  250,000 children died of TB 
in 2016.
[6] 
India is the country with highest burden of TB. The WHO TB statistics for 
India in 2017 give an estimated incidence figure of 2.79 million cases of TB. In this 
about 3% were found to be HIV positive. About 40% of the Indian population is 
infected with tuberculosis bacteria. 
In Tamilnadu, Revised National Tuberculosis Control Programme (RNTCP) 
has reported for about 77,100,000 cases for TB.
[7] 
Tuberculosis treatment consists of a multi- drug regimen with duration of 6 to 
8 months. The preferred first line drugs were, 
 Isoniazid 
 Rifampicin 
 Pyrazinamide and 
 Ethambutol 
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When the bacterial strains become resistant to one or more of these drugs, second line 
drugs are used. Second line drugs are, 
 Streptomycin 
 Kanamycin 
 Fluoroquinolones 
 Ethionamide and 
 P- aminosalicylic acid 
               Drugs associated toxicity is an unfortunate outcome of this tubercular 
treatment. Hepatotoxicity is the major side effect for almost all first-line anti-
tuberculosis drugs. Pyrazinamide accounts for exanthema and arthralgia.
[8] 
                The emergence of MDR and XDR and complications of the anti-
tuberculosis drugs there is an urgent  need  for alternative which could  fulfil the need. 
                Attention across the world has focused towards traditional system of 
medicine, as it is affordable, safe, efficient and culturally acceptable. 
              Indian system of medicine is of great antiquity. Our country is blessed with a 
plethora of traditional medicines and practises. Siddha system of medicine, the 
foremost of all other medical systems, generated from Dravidian culture and it is 
flourished in the period of Indus valley civilization. It’s origin dates back to BC 
10,000 to BC 4000 ( Sambasivampillai, 1931; Pillai, 1979) and it is exclusively 
practised in Tamilnadu. 
              Siddha denotes which means achievement in life arts such as, 
 Alchemy (Vaatham) 
 Medicine (Vaithiyam) 
 Yoga (Yogam) 
 Philosophy (Thathuvam) 
             Siddhars are spiritual scientists who explored and explained the reality of 
nature and its relationship to mankind. They were great philosophers and physicians 
and postulated the concept of spiritualism for self-improvement. 
.          There were many group of Siddhars, in which there are mainly 18 Siddhars, 
who are named as “PATHINEN SIDDHARGAL”.  
                        “Medicine means the prevention of physical illness 
        Medicine means the prevention of mental illness 
        Prevention means to avert illness 
        Medicine therefore is the prevention of death”  
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          This is an interesting definition of medicine by Thirumoolar. Siddhars used the 
Siddha medicine to retain their body and mind from ageing and also to prevent the 
body from diseases to attain spiritual perfection, a semi-divine state. 
         The Siddhars uniformly believed that a human body is composed of  96 basic 
factors. These are called as “THATHUVAS”. Traditional systems of medicine 
throughout the world are based on the humoral theory. There are three “HUMOURS” 
in Siddha system of medicine namely, Vadham, Pitham and Kapham. These are the 
combination of Panchaboodhas. 
          Earth and water form Kapha, fire Pitha, air and space form Vadha. These three 
thadhus are nourished by their respective elements present in food. 
         In Siddha system of medicine classification of diseases mainly based on Vadha, 
Pitha and Kapha factors. The treatment in Siddha medicine is aimed at keeping the 
three dhoshas in equilibrium. So a proper diet, medicine and a regimen of life is 
advised for a healthy living and restore equilibrium of dhoshas in diseased 
conditions.
[9] 
         In Siddha, “SAYAM” is the disease correlated with tuberculosis. It is also 
known as “Ilaippu noi” because of the main symptom of this disease are emaciation 
of whole body before the patient knows about his health. “EELAI” due to production 
of phlegm in large amount, “YAKSHMA” is because the disease is cross infected in 
many chronic diseases. 
         The major symptoms of this disease are evening rise of temperature, severe 
cough, increased sweat at night, emaciation of the body and the cause of the disease is 
starvation, any chronic diseases, malnutrition and immunosuppression.
[10] 
         There are numerous single herb and poly herbal formulations are available in 
Siddha to treat tuberculosis. One of the polyherbal formulation mentioned for TB is 
“THIRIJADHATHI MATHIRAI” from the literature of “Anubhava Vaithiya Deva 
Ragasiyam” written by Dr. K. Radhakrishnan L.I.M. 
        “Thirijadhathi mathirai” – Thirisatham means lavangapattai, lavangapathiri 
and elakkai. It also contains thippili, karkandu, dhratchai, adhimadhuram and 
karchurakai. 
         In this lavangapattai, lavangapathiri, elakkai and thippili have anti-microbial 
activity against tuberculosis especially MDR- TB. Elakkai and adhimadhuram contain 
expectorant activity. They also posses immunomodulatory activity.  
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        So the author  considered the trial drug “THIRIJADHATHI MATHIRAI” will 
be effective, non-toxic, cost effective in  treating  TB. Though the medicine is present 
in literature there is no scientific validation to prove the efficacy and effectiveness of 
this drug. So an attempt was made to standardize this medicine through 
standardization protocol, toxicological profile, anti- tuberculosis, bronchodilator and 
anti- histamine activity in vitro. 
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                                       2. AIM AND OBJECTIVES 
 
AIM: 
The present investigation was aimed to validate the safety and efficacy of the Siddha 
polyherbal formulation “Thirijadhathi mathirai” for its Anti tuberculosis In-Vitro and 
Bronchodilator and Anti histamine activity in animal model respectively. 
OBJECTIVES: 
The key objectives of the study are: 
 Having a collective review of the literature. 
 Preparing the drug according to Siddha classical text. 
 Subjecting the drug to physico-chemical standardization. 
 Analyzing the drug chemically for detection of acid and basic radicals. 
 Focusing the drug for analytical assessment. 
 Studying the toxicity profile of Thirijadhathi mathirai according to OECD guidelines. 
 Determining the pharmacological activity (In Vitro anti-tuberculosis activity) of 
Thirijadhathi mathirai. 
 Evaluation of bronchodilator activity of Thirijadhathi mathirai in guinea pigs. 
 Evaluation of anti-histamine activity of Thirijadhathi mathirai by inducing 
bronchospasm in guinea pigs by exposing them to histamine aerosol under standardized 
conditions. 
  Analyzing all the above study results to validate the benefits of Thirijadhathi 
mathirai. 
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3. REVIEW OF LITERATURE 
3.1 DRUG REVIEW: 
“THIRIJADHATHI MATHIRAI” 
Ingredients: 
 Lavangapattai (Cinnamomum verum) 
 Lavangapathiri ( Cinnamomum tamala) 
 Elakkai ( Eletteria cardamomum) 
 Thipilli (Piper longum) 
 Karkandu ( Sugar candy) 
 Dried dhiratchai ( Vitis vinifera) 
 Adhimathuram (Glycyrrhiza glabra) 
 Karchurakai (Phoenix dactilifera) 
 
3.1.1 GUNAPADAM ASPECT OF THE DRUG: 
1. LAVANGAPATTAI:
[11a] 
Other Name: 
Karuvapattai 
Vernacular Names: 
Eng : Bark of cinnamon 
Tel :  Lavangapatta 
San : Twak 
Mal : Lavangapatta 
Kan : Dala-Chinni 
Parts Used:  Bark 
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Properties and Action: 
Taste  : Hot, sweet 
Potency    : Hot 
Division       : Sweet 
Action         : Carminative, Stimulant, Aphrodisiac 
 
General Properties:   
        “                            
                             -        
                                     
                     ”. 
         
        “                                
                               -       
                                    
                         .” 
-              
 
 
Indications: 
 It is useful to treat snake bite, spider bite, asthma and cough. 
 It acts as refrigerant 
 It cures internal piles and stomach discomfort. 
 It is useful to treat diarrhoea 
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2. LAVANGAPATHIRI:
 [11b] 
Other Names: 
Thalisapathiri, Thamalapathiri 
Vernacular Names: 
Eng : Cassia cinnamon 
Tel : Adavi- lavangapathiri 
San : Tamalapathiram 
Mal : Paccila 
Kan : Kadu lavanga patte 
Parts Used:        Leaf        
Properties and Action: 
Taste  : Hot 
Potency      : Heat 
Division      : Sweet 
Action       : Carminative, Stimulant, Stomachic, Diaphoretic 
General Properties: 
“                             
                        -        
                                  
                        .” 
-              
 
Indications: 
 It is used to treat syphilitic fever, cough, thirst, asthma, vomitting and oral 
ulcer. 
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3. ELAKKAI:
 [11c]
 
 Other Names: 
Aanji, Korangam, Thudi 
Vernacular Names: 
Eng : Cardamom seeds 
San :  Ela 
Mal :  Elattari 
Hin :  Elachi 
Parts Used:        Seeds        
 
Properties and Action: 
Taste       : Hot 
Potency     : Heat 
Division     : hot 
Action       : Carminative, Stimulant, Stomachic. 
General Properties: 
         “                         
                             
                        
                      
                         
                       
                         
          ஏ       …… 
-            
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Indications: 
 It is used to treat cough, diarrhoea and thickened sputum. 
 
4. THIPILLI:
 [11d] 
Other Names :  
 Saram, Pippli, Kaman, Koli, Ambu, Arkathi, Kanai, Adhi marunthu, Vaidegi. 
Vernacular names 
 English : Long pepper 
 Sanskrit : Pippali 
 Telugu  : Pippilu 
 Kannada : Hippili 
 Malayalam : Thipilli 
Part used:  Dried fruit 
Properties and action 
 Taste  : Sweet 
 Nature  : Hot 
 Division : Sweet 
 Action  : Carminative, Stimulant. 
General characters  
         “                       
                    -         
                                 
                    ”      
              -             
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Indications:  
 It cures anaemia, fatigue, headache, sinusitis, pulmonary tuberculosis, cough 
and bronchial asthma. 
Therapeutic uses: 
Powder : Administered with honey will relieve cough, asthma and hoarseness. 
Infusion : Infusion made of 10 peppers with honey makes a good expectorant 
Oil  : Rubbed externally in sciatica and paraplegia. 
Fruit  : Given to women after parturition for fever. 
 
5. KARKANDU  (sugar candy):
 [11e] 
Other Names :  
 Punarpusam, Ekku, Vei 
Vernacular names 
 English : Sugarcane 
 Sanskrit : Ikshu 
 Telugu  : Cheruku 
 Kannada : Khabbu 
 Malayalam : Karinpa 
Part used:  Root, Sugar 
Properties and actions: 
 Taste  :  Sweet 
 Nature  : Cold 
 Division : Sweet 
REVIEW OF LITERATURE 
 
ANTI TUBERCULOSIS OF THIRIJADHATHI MATHIRAI  15 
 
 Actions : Demulcent, Antiseptic, Refrigerent, Laxative and Diuretic.                  
General characters: 
                    “                          
                                       -        
                                              
                                       .” 
                 -             
Indications: 
 It is used to treat gum swelling, cough, vomiting and iyaazhal. 
 
6. DRIED DHIRATCHAI:
 [11f] 
Other Names:   
  Aravaaram, Kodimunthiri, Kodimunthirigai, Madhurasam, Kothirigai, 
Dhirakam, Palothamai. 
Vernacular Names: 
 English : Grapes          
 Sanskri : Draksha 
 Telugu  : Draksha 
 Kannada : Draksha            
Part used:     Fruit 
Properties and actions: 
 Taste  : Sweet 
 Nature  : Cold 
 Division : Sweet 
 Actions : Laxative, Refrigerant, Diuretic, Nutritive. 
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Indications: 
 It is used to treat constipation, anaemia and bleeding disorders. 
 It can be given for the patients with fever, cough, jaundice and tuberculosis. 
 It is used as refrigerant. 
 It is used as tonic and improves the haemoglobin level. 
 
7. ATHIMATHURAM: 
[11g] 
Other Names: 
Athingam, Mathugam, Kundri ver. 
Vernacular names: 
 Sanskrit : Yashti - madhukam 
 English : Indian liquorice 
 Hindi  : Jathi - Madh 
 Telugu  : Yashti - madhukam 
 Malayalam : Iratti - Madhuram 
Part used:    Root 
Properties: 
 Taste  : Sweet 
 Nature  : Cold 
 Division : Sweet 
 Actions : Demulcent, Laxative, Tonic, Mild Expectorant. 
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General characters: 
“கத்தினரி ப௃ப்஧ிணினரல் யய௃புண் தரகங் 
கண்ணணரய்உன் நரதம்யிக்கல் யலிவயண் குட்டம் 
஧ித்தவநலும் புய௃க்கி கிரிச்சபம் ஆயர்த்த 
஧ித்தநத ப௄ர்ச்சச யிட ஧ரகம் வயப்஧ந் 
                      
                         
                    இந்து 
                          ” 
                              -         ஧ர   
 
Indications: 
 It reduces excessive thirst, hiccough and leucoderma. 
 It cures disease of bones, jaundice and burning micturition.  
 Melts phlegm due to Iyam, and reduces pitha kutrams. 
 It is used to treat faint, reduces over body heat. 
 It induces the aphrodisiac activity in males. 
 
Uses :
( 14b)
 
 The root is also used in irritable conditions.   
 Root powder mixed with lime juice used as a remedy for swelling and pain. 
 In China, the Adhimathuram root is a great important drug in Chinese 
pharmacy, for strengthening of bone and muscles and increasing physical 
strength and curing wounds. 
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8. KARCHURAKAI:
[11h] 
Other Name:   Pereechu 
Vernacular names: 
 Sanskrit :   Kharjjuram 
 English :   Date palm 
 Hindi  :   Kajur 
 Telugu  :   Karjuramu 
 Malayalam :   Perich- cha 
Part used: Fruit 
Properties: 
 Taste  :Sweet 
 Nature  :Heat 
 Division :Hot 
 Action  :Demulcent, Laxative, Tonic, Nutritive, Diuretic. 
General characters: 
                    “                          
                                       -        
                                              
                                     .”     
-              
Indications: 
 It is used to treat increased salivary secretion, diabetes and diarrhoea. 
 It increases the appetite. 
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3.1.2 MODERN  ASPECT OF THE DRUG: 
1. LAVANGAPATTAI: 
Botanical Name: Cinnamomum verum 
Taxonomical Classification:
[12] 
Kingdom : Plantae 
Subclass : Magnoliids                             
Order  : Laurales 
Family  : Lauraceae 
Genus  : Cinnamomum 
Species : verum                                         Fig.no.1 Cinnamomum verum 
Distribution:
[13] 
It is native to Srilanka and found wild in Western and Southern India. It is 
cultivated in Malay Islands. 
Parts Used: Bark 
Botanical Description: 
An evergreen tree, 8-16m high, with reddish brown bark having numerous 
small warts. Leaves ovate or elliptic ovate, thick, leathery, subacute or shortly 
acuminate, shining green on upper surface, main nerves 3-5 from petioles. Flowers 
minute, in axillary or sub-terminal cymes or panicles. Fruits dark, purple, single 
seeded berry. 
Chemical Constituents: 
Linalool, benzyl acetate, cinnamic aldehyde, eugenyl acetate, cinnamyl 
acetate, benzyl benzoate, cinncassiol C1 glucoside, cinncassiol C2 and C3, diterpenes, 
cinnamaldehyde, pinene, cymene, cumic aldehyde, esters of isobutyric acid, 
dipentenoids, cinnamyl alcohol, polymeric proanthocyanidin, arabinoxylan. 
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Actions and Uses: 
The bark is aromatic, astringent, aphrodisiac, deodorant, stimulant, 
expectorant, febrifuge, diuretic and carminative. It is useful in bronchitis, asthma, 
cardiac diseases, diarrhoea, nausea and vomiting, urinary disorders, fever, halitosis 
and restoring the normal colour on the face. Cinnamon oil is stomachic, carminative, 
emmenagogue, styptic and useful in anorexia, inflammations, abdominal pain, 
toothache and tubercular ulcers. 
Pharmacological Activities: 
 Anti-complement, anti-allergic, anti-bacterial, anti-microbial, anti-fungal, 
anti-oxidant, insecticidal and lipolytic. 
 
2. LAVANGAPATHIRI: 
Botanical Name: Cinnamomum tamala 
Taxonomical Classification:
[14] 
Kingdom : Plantae 
Subclass : Magnoliids  
Order  : Laurales 
Family  : Lauraceae 
Genus  : Cinnamomum 
Species : tamala                                   Fig.no.2 Cinnamomum tamala 
 
Distribution:
[15] 
                     A small evergreen, moderate sized tree growing in sub-Himalayan tracts 
from Jammu eastwards to Bhutan between altitude 900-2300 m and in Khasi hills, 
altitude 900- 1200m. 
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Macroscopic Characters: 
 Leaves are simple, linear lanceolate, 5 to 15 cm long, 3 to 6 cm broad, midrib 
prominent at the lower side, with three lateral veins arising from the base, converging 
towards the apex, margin entire, apex acute- acuminate, base symmetrical, upper 
surface smooth shining and leathery, lower surface slightly rough, somewhat 
pubescent, petiole 7 to 15 mm long, centrally grooved; dull green in colour. Odour 
pleasant and aromatic, taste sweet, spicy and mucilaginous. 
Microscopic Characters: 
  PETIOLE: TS of the petiole is oval in outline with a slight central depression 
on the upper side, epidermis covered with thick cuticle and bears trichomes like that 
of leaf. Hypodermis consists of 4 to 8 rows of collenchymatous tissue, encircling the 
wide parenchymatous cortex, filled with starch grains and oil globules, more crowded 
around the centrally located twin, unequal sized fibro-vascular bundles. Cells 
containing volatile oil and mucilage canals transversed throughout the cortex. 
LEAF: TS passing through the midrib convexly protrudes on the lower side and 
obliquely on the upper side and shows centrally located twin fibro- vascular bundles 
of unequal size, unlike the lateral vein where lies only one meristele. Midrib contains 
collenchymatous tissue above and below. Meristele consists of radially arranged 
central xylem and phloem, encircled by a ring of pericyclic fibres. Two rows of 
palisade lie underneath the upper epidermis. Glandular trichomes with unicellular 
stalk and unicellular head, sessile trichomes, pearl gland are also present, oil 
containing cells and circular to oval mucilage canals transversed throughout the 
lamina and midrib tissue and starch grains in mesophyll cells. 
Chemical Constituents: 
 Eugenol, linalool, ∞- pinene, camphene, β- pinene, benzaldehyde, myrcene, 
limonene, p- cymene, benzyl acetate, ∞- terpineol, cinnamaldehyde, geraniol, linalool 
acetate, benzyl cinnamate and tannins. 
Actions and Uses: 
  The dried leaves are useful to treat cough, asthma and bronchitis.   
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Pharmacological actions: 
              Hypoglycaemic, hypolipidaemic, anti-bacterial activities, fungicidal, 
fungistatic. 
 
3. ELAKKAI: 
Botanical Name: Elettaria cardamomum 
Taxonomical Classification:
[14] 
           Kingdom : Plantae 
           Subclass : Monocots  
           Order  : Zingiberales 
           Family  : Zingiberaceae 
           Genus  : Elettaria 
           Species  : cardamomum                          Fig.no.3 Elettaria cardamomum                                   
Distribution:
[16] 
 
  It is a native of the moist evergreen forests of South India, growing wild in 
the Western Ghats, between 800- 1600 m. It is commonly cultivated in Kerala, 
Karnataka and Tamilnadu.
 
Parts Used: Seed 
Botanical Description: 
 A tall herbaceous perennial with branching subterranean root stock and several 
erect stems up to 3m high. Leaves 30-90 cm long, subsessile, elliptic or lanceolate 
with sheathing base. 
  Flowers borne in panicles, 60-120 cm long, arising from the bse of vegetative 
shoots; panicles generally upright at first and ultimately pendent or lying on the 
ground; flowers white or pale green with a central lip streaked with violet.  
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 Fruits trilocular, subglobose or fusiform to ovoid capsule. Seeds 15-20 per 
pod, brownish black, angled, rugose, covered with a thin mucilaginous membrane. 
Chemical Constituents: 
 ∞- Pinene, sabinene, myrcene, limonene, cineol, cymene, methyl heptenone, 
linalool, linalyl acetate, ∞ & β- terpineol, ∞- terpinyl acetate, borneol, nerylacetate, 
geraniol, nerol, neolidol, heptacosane, 1, 8- cineole, camphene, terpinene, ∞-
humulene, E-4, 8- dimethyl- 1, 3, 7, 11- tridecatetraene (essential oil of fruits and 
leaves). 
Actions and Uses: 
               Seeds are aromatic, refrigerant, stimulant, carminative, digestive, stomachic, 
diuretic, cardiotonic, alexiteric, expectorant, tonic and abortifacient. They are useful 
in anorexia, vomiting, giddiness, dyspepsia, gastric disorders, asthma, bronchitis, 
haemorrhoids, strangury, dysuria, renal and vesical calculi, halitosis, cardiac 
disorders, hyperdipsia, burning sensation, debility and defects of vision. 
Pharmacological Activities: 
              Hepatoprotective, anti- inflammatory, analgesic, antispasmodic, 
antimicrobial and antifungal. 
 
4. THIPPILI: 
Botanical Name: Piper longum 
Taxonomical Classification:
[17] 
Kingdom : Plantae
 
Subclass : Magnoliids 
Order  : Piperales 
Family  : Piperaceae 
 Genus  : Piper                                                            
 Species : longum                                    Fig.no.4 Piper longum 
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Distribution:
[18] 
 It occurs in hotter parts of India from Central Himalayas to Assam, Khasi and 
Mikir hills, lower hills of Bengal and evergreen forests of Western Ghats from 
Konkan to Travancore. 
Parts Used: Fruit, root 
Botanical Description: 
  A slender, aromatic climber with perennial woody roots, stems creeping, 
jointed. Leaves ovate, cordate, subacute, entire, glabrous. Spikes cylindrical, 
pedenculate, male larger and slender, female 1.3- 2.5 cm long. Fruits ovoid, yellowish 
orange, sunk in fleshy spike. 
Chemical Constituents: 
 Stem and roots: Two alkaloids piperlongumine and piperlonguminine 
characterised as N- (3, 4, 5- trimethoxy cinnamoyl)- ∆- piperidin- 2- one and 
isobutylamide of piperic acid respectively.  
 Essential oil from the dried fruit: n- hexadecane, n- heptadecane, n - 
octadecane, n - nonadecane, n- eicosane, n-heneicosane, ∞ - thujene, terpinolene, 
zingiberene, p - cymene, p - methoxy acetophenone, traces of dihydrocarviol, 
phenylethyl alcohol and two sesquiterpenes. 
 Roots: Piperine, piplartine, triacontane, dihydro- stigmasterol, reducing 
sugars, glycosides, sesamin and methyl - 3, 4, 5 - trimethoxycinnamate.  
 Stem and fruits: Major alkaloid piperine and sesamin  
 Essential oil: Sesquiterpene hydrocarbon, caryophyllene, a sesquiterpene 
alcohol, carbonyl compound.  
 Fruit: N- isobutyldeca- trans- 2- trans- 4 - dienamide, piperine, piplartine and 
a lignin d- sesamin, two piperidine alkaloids- pipernonaline and piperundecalidine. 
 Seed: Sylvatin, sesamin and diaeudesmin. 
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Actions and Uses: 
 The root is bitter, thermogenic, tonic, diuretic, purgative, expectorant, 
anthelmintic, stomachic, digestive and emmenagogue. They are useful in gout, 
limbago, dyspepsia, apoplexy, gastralgia and splenopathy.  
 Dried spikes are acrid, vermifuge, mildly thermogenic, stomachic, 
aphrodisiac, carminative, expectorant, febrifuge, laxative, digestive, emollient and  
antiseptic. They are useful in anorexia, dyspepsia, vomiting, flatulent colic, diarrhoea, 
cholera, dysentery, asthma, bronchitis, coryza, hiccough, consumption, gastric 
disorders, epilepsy, insomnia, fever, gonorrhoea, haemorrhoids, gout and lumbago.
   
 The fruits are used after child birth to check postpartum haemorrhage, as a 
cholagague in bile duct and gallbladder obstruction.  
 Unripe fruit is used as a tonic. A decoction of immature fruits and roots is used 
in chronic bronchitis, cough and cold; also used in palsy, gout, rheumatism and 
lumbago. 
Pharmacological Activities: 
  Antibacterial, anti-inflammatory, insecticidal, antimalarial, CNS stimulant, 
anti- tubercular, anti- helminthic, hypoglycaemic, antispasmodic, cough suppressor, 
anti-giardial, immunostimulatory, hepatoprotective, analeptic, antinarcotic and 
antiulcerogenic. 
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5. KARKANDU: 
BOTANICAL NAME: Saccharum officinarum 
TAXONOMICAL CLASSIFICATION:
[14] 
Kingdom : Plantae 
Subclass : Monocots 
Order  : Poales 
Family  : Poaceae 
Genus  : Saccharum 
Species : officinarum                      Fig. no.5 Saccharum officinarum 
Distribution:
 [19] 
                   It is extensively cultivated in hotter parts throughout India.  
Parts Used: Root, stem 
Botanical Description: 
                  Perennial tall herb, upto 6.5 m high with stems of varying thickness and 
colour, many noded. Leaves 1.6 m x 6 cm, linear lanceolate, midrib very stout, erect 
or drooping. Raceme upto 10 cm long, fragile, pedicel short. Spikelets lanceolate, 
upto 0.1 cm long, usually surrounded by long silky hair from their base. Grain oblong 
to subglobose, subterete, flesh coloured. 
Chemical Constituents: 
                   5-0- Methylapigenin and 3’,4’,5,7-tetrahydroxy-3-6-dimethoxyflavone, 
aminoacids, phenylalanine, arginine, saccharetin, methionine, pantothenic acid, biotin. 
Action And Uses: 
                  They act as Expectorant, Haemostatic and Tonic. They are useful in cough, 
bronchitis, anaemia, emaciation, general debility. 
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Pharmacological Activities: 
                  Antioxidant, Expectorant and Tonic. 
 
6. DHIRATCHAI: 
Botanical Name: Vitis vinifera 
Taxonomical Classification:
[14] 
Kingdom : Plantae 
Subclass : Rosids 
Order  : Vitales 
Family  : Vitaceae 
Genus  : Vitis 
Species : vinifera                            Fig.no.6 Vitis vinifera 
 
Distribution:
[20] 
                  It is cultivated in Jammu-Kashmir, Himachal Pradesh, Uttar Pradesh, 
Rajasthan, Punjab, Haryana, Delhi, Maharashtra, Karnataka, Andhra Pradesh and 
Tamilnadu.  
Parts Used: Ripe fruit (dried), leaf, flower, stem. 
Botanical Description: 
                 A large, perennial tendril climber, tendril leaf opposed, often bifid. Leaves 
simple, rotund-cordate or orbicular cordate, dentate, 3-7 lobed, 10-12 cm across, 
glabrous above, tomentose beneath. Flowers in long peduncled, leaf-opposed cymes, 
greenish or white. Fruits (berry) globose, ovoid or oblong, varying in size, pale green 
or purple. Seede 2-4, oblong-obovoid, brown, with a discoidal tubercle on the back. 
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Chemical Constituents: 
 Fruit: 3-monoglucosides of delphinidin,  petunidin, peonidin, malvidin, acetyl 
and coumaryl glucosides, biflavanoids, malic acid, tannic acid, dehydroascorbic acid, 
β-sitosterol, ergosterol, glucose, fructose, galactose, mannose, arabinose, rhamnose 
and aminoacids like alanine, arginine and proline. 
Action and Uses: 
 The fruits are sweet, refrigerant, laxative, demulcent, cardiotonic, haematinic, 
diuretic, aphrodisiac, rejuvenating, nervine tonic, digestive, suppurative, expectorant 
and tonic. 
 They are useful in burning sensation, constipation, amentia, cardiac debility, 
haemoptysis, haemorrhages, anaemia, consumption and wasting diseases, cough, 
asthma and bronchitis. 
Pharmacological Activities: 
                 Antifungal, angiotensin-converting enzyme (ACE) activity, 
hepatoprotective, antioxidant, wound healing, antibacterial, breast cancer suppressor, 
antimutagenic and  cardioprotective. 
 
7. ADHIMADHURAM:
[21]
 
Botanical Name: Glycyrrhiza glabra 
Taxonomical Classification: 
Kingdom : Plantae 
Subclass : Rosids 
Order  : Fabales 
Family  : Fabaceae 
Genus  : Glycyrrhiza  
Species : glabra                                 Fig.no. 7 Glycyrrhiza glabra 
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 Distribution:
[22] 
                     It is distributed in the Sub-tropical and warm temperature regions of the 
world, chiefly in the Mediterranean countries, South Europe, Asia Minor, Egypt, 
Turkistan, Iran, Siberia, Persia, Arab countries and Afganistan. 
                      In India, it is reported to be cultivated in Baramulla, Srinagar, Jammu, 
Dehra Dun, Delhi and South India. 
Parts Used: Root 
Botanical Description: 
  It is hardy herb or undershrub attaining a height up to 2 m; leaves multifoliate, 
imparipinnate; flowers in axillary spikes, papilionaceous, lavender to violet in colour; 
pods compressed containing reniform seeds. 
Chemical Constituents: 
 Glycyrrhizine, prenylated biaurone, 4-methyl coumarin, liqcoumarin, 
isoflavone, quercetin, 
Action and Uses: 
 The roots are sweet, refrigerant, emetic in large doses, tonic, diuretic, 
demulcent, mild laxative, aphrodisiac, expectorant, emmenagogue, haemostatic and 
intellect promoting.  
 They are useful in hyperdipsia, cough, bronchitis, ulceration of urinary tract, 
retention of urine, gastralgia, gastric ulcer, cephalgia, fever, skin diseases, ophthalmic 
diseases, pharyngitis, consumption, epilepsy, anaemia, urticaria.  
 Decoction of root is good wash for falling and greying of hair. It is externally 
applied for cuts and wounds. 
Pharmacological Activities: 
 Smooth muscle depressant, antimicrobial, hypolipidaemic, antiviral, 
hypotensive, hepatoprotective, antiexudative, expectorant, antimutagenic, anti-
inflammatory. 
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8. KARCHURAKAI: 
 Botanical Name:  Phoenix dactylifera 
Taxonomical Classification:
[14] 
Kingdom : Plantae
 
Subclass : Monocots 
Order  : Arecales 
Family  : Arecaceae 
Genus  : Phoenix   
Species : dactylifera                     Fig.no.8 Phoenix dactylifera   
 Distribution:
[23] 
                     Dates have been a staple food of the Middle East and the Indus 
Valley for thousands of years. Dates cultivated in eastern Arabia, Iraq, Mesopotamia.  
Parts Used: Fruit 
Botanical Description: 
Date trees typically reach about 21–23 metres (69–75 ft) in height,[7] growing 
singly or forming a clump with several stems from a single root system.  
The leaves are 4–6 metres (13–20 ft) long, with spines on the petiole, 
and pinnate, with about 150 leaflets.  
The leaflets are 30 cm (12 in) long and 2 cm (0.79 in) wide. The full span of 
the crown ranges from 6–10 m (20–33 ft).  
The date palm is dioecious, having separate male and female plants. They can 
be easily grown from seed, but only 50% of seedlings will be female and hence fruit 
bearing and dates from seedling plants are often smaller and of poorer quality.  
Most commercial plantations thus use cuttings of heavily cropping cultivars. 
Plants grown from cuttings will fruit 2–3 years earlier than seedling plants. 
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Chemical Constituents:
[24] 
 Anthocyanins, phenolics, sterols, carotenoids, procyanidins and flavonoids.  
Actions and Uses: 
            It is used to treat loss of appetite. It also enhances the immunity and used as 
tonic. 
Pharmacological Activities:
[25] 
 Free radical scavenging, antioxidant, antimutagenic, antimicrobial, anti-
inflammatory, gastroprotective, hepatoprotective, nephroprotective, anticancer and 
immunostimulant activities.  
 
3.2.1 SIDDHA ASPECT OF THE DISEASE 
Tuberculosis (Ilaippu noi) 
Introduction:  
 Tuberculosis is one of the major diseases which occur due to the default of 
Kapha. This disease is also called Ellai, Kaba noi,  King of diseases (arasa noy), 
Kshayam, Rajayakshma,  Yakshma and  Shushashai. As the body gets emaciated 
much in this disease, it is called emaciating disease or Ilaippu noi in Tamil. 
Aetiology: 
 Frequent starvation 
 Wakefulness at night without sleep 
 Excessive hard work beyond one’s ability 
 Suffering from many other diseases for a longer duration 
 Suffering due to poverty 
 Mental depression due to imprisonment 
 Consuming poor nutritious food 
 Living in places of poor ventilation 
 Using cannabis 
 Excess intake of pungent and salty food 
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 Syncope to a large extent 
 Consuming stagnant water 
 Consuming tasteless foods 
 Consuming water on limestone bed 
 Wandering in hot sun 
 Being near to excess heat 
 Excess sorrowfulness 
 Telling lies 
 Stealing 
 Being false to relatives 
 Speaking ill of others 
 Speaking unparliamentary words 
 These are the reasons for tuberculosis according to Siddha literatures. In 
general, the basic factors in the incidence of this disease are the debilitating condition 
of the body with loss of immunity and mental disturbances. This will also occur as an 
associated disease of diabetes mellitus, etc. 
Signs and symptoms 
 Rise of temperature in the evening 
 Sore throat 
 Rhinitis 
 Loss of brightness of vision 
 Cough 
 Accumulation of sputum 
 Pleurisy 
 Deafness 
 Vomiting 
 Excess diarrhea 
 Sweating at night 
 Anorexia 
 Craving 
 Loss of appetite 
 Being always dull 
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 An illusory feeling of mud, stones, dust and ants being mixed with food 
substances, trembling due to a false feeling of paleness of the body, oedematous legs 
and severe emaciation which occur after a prolonged illness. 
 Feeling of sadness on seeing one’s own body repeatedly. 
 Hallucinations like burning of towns, dryness of ponds, rivers and lakes, attack 
by dangerous birds, snakes etc... and destruction of forests and mountains, 
Overgrowth of nails and hairs. 
ண஥ரய்த் வதரகுப்பு யப஬ரறு:[26] 
  “தர஦ர஦யிச஭ப் வ஧னுஞ்சனம் ஧஦ிவபண்டரகும் 
   தரக்கர஦ ஧ிபநவநரன்று சனந்தர வ஦ன்று 
  யர஦ர஦ பரஜட்சம் சயசினச் சனந்தரன் 
   நய௃வுசூத்திப சனந்தரன் யரதச் சனந்தரன் 
  பூ஦ர஦ ஧ித்தச்சனம் ணசட்஧த் ணதரடு 
   ஧ிபண்டணதரர் யரத஧ித்தச் சனப௃ நரகும்  
  கர஦ர஦ யரதணசச் டுநட்ச னந்தரன் 
   கய௃ம்஧ித்தச் ணசட்டுநத்தின் சனப௃ நரணந. 
  ஆகின்஫ யிகரபச்சனந் வதரந்தச் சனந்தரன் 
   அடங்கலுணந ஧஦ிவபண்டு யிதப௃ நரகும் 
  ணயகின்஫ கஞ்சரயரல் நிகுந்த வுப்஧ரல் 
   நீ஫ினணதரர் கரபத்தரல் நிகந னக்கரல் 
ணதரகின்஫ நய௃ந்தீட்டரற் சுச஦ ஥ீபரல் 
   ய௃சினில்஬ரப் ஧தரர்த்தங்கள் சுக்கரன் தண்ணீர் 
  யரகின்஫ யக்கி஦ினரல் நிகுந்த வயய்னில் 
   யய௃த்தத்தில் சனணபரக நய௃வுங் கரணண. 
  கரணணய கற்஧மித்தல் வ஧ரய்ணன வசரல்஬ல் 
   க஭யரடல் ஧ி஫ர்வ஧ரய௃ச஭க் கண்டிச் சித்தல் 
  ஆ஦ணய னடுத்ணதரடசபக் வகட஥ிச஦த்தல் 
   அகதி஧ப ணதசினசபக் னகந்சத வசரல்஬ல் 
  ஊ஦ணய ஧ந்துசய யஞ்சித்ணத யுண்ணல் 
   உதரசி஦நர இகழ்ந்ணதரசப இகழ்ச்சி ண஧சல் 
  ணயணணய கரதி஦ிற் ணக஭ரத வசரல்ச஬ 
   நிகச்வசரன்ண஦ரர் சனத்தில்யந்து வநலிகு யரணப. “ 
         - யூகி ப௃஦ியர் 
REVIEW OF LITERATURE 
 
ANTI TUBERCULOSIS OF THIRIJADHATHI MATHIRAI  34 
 
Classification of the disease 
Tuberculosis has the characteristic features of destroying all the seven body 
tissues and reducing the strength and stamina of the body. This disease is classified 
not only on the basis of the affected life forces but also of the Vayu’s like Uthanan 
and Abanan. The deranged life forces and Vayu’s specifically attack certain organs or 
places and so the signs and symptoms of the diseases vary according to the site of the 
lesion. On this basis, Yugi classified the disease into 12 types in Siddha system; 
Yugi’s  classification alone is generally followed. 
 It is as follows: 
1. Brahma ilaippu noi 
2. Rasa ilaippu noi 
3. Vaishya ilaippu noi 
4. Sutthira ilaippu noi 
5. Vatha ilaippu noi 
6. Pitha ilaippu noi 
7. Kapha ilaippu noi 
8. Vatha pitha ilaippu noi 
9. Vatha Kapha ilaippu noi 
10. Pitha Kapha ilaippu noi 
11. Vihara ilaippu noi 
12. Thontha ilaippu noi 
Signs and symptoms of different varieties of tuberculosis 
1. Brahma ilaippu noi  
 Emaciation, cough, expectoration of sputum along with watery discharge from 
lesions, blood-stained sputum, reduction of body  temperature, bleeding from eyes, 
fever, persistent mental confusion, loss of taste and vomiting. 
2. Rasa ilaippu noi 
 Head ache, pain in the chest, expulsion of yellowish sputum, pain in the 
trachea, change in voice, pain all over the body, heat throughout the body and 
vomiting with continuation of cough are the signs and symptoms of this disease. 
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3. Vaishya ilaippu noi 
 Weakness in both the limbs, inability to tolerate the sunlight, fever with excess 
perspiration, cough with expectoration, anaemia, constipation, intense suffering, 
yawning  and shivering of the body are the signs and symptoms of this disease. 
4. Sutthira ilaippu noi 
 Inflammation of the eyes, lacrimation in the eyes, cough, ulceration of trachea, 
shivering due to cold in the early morning, syncope, pain, sweating, vomiting and 
sputum mixed with vomitus, stickiness of sputum in throat, burning sensation, 
piercing pain, yawning and constipation are the signs and symptoms of this disease. 
5. Vatha ilaippu noi 
 Emaciation of the body, headache, hiccough, pain in the ribs, pain in the 
centre of the back, vomiting, fever, thirst, pain in the shoulders, hands, legs and neck, 
diarrhoea, cough, loss of sleep, bitterness in the tongue and chest pain ( piercing pain)  
are the signs and symptoms of this disease. 
6. Pitha ilaippu noi 
 Dyspnoea, shrinking in the sides of the chest and neck, cough with 
expectoration, haematemesis, sore throat, syncope, indigestion, anaemia, jaundice, 
yellow discolouration of urine, fever, shivering with cold, sweating, excess coldness, 
muscle pain, intense suffering and discomfort are the signs and symptoms of this 
disease. 
7. Kapha ilaippu noi 
 Vomiting in continuation of cough, sputum in vomitus, belching or eructation, 
loss of taste, diarrhoea, sore throat, pallor of the body, fatigue, rhinitis ( running nose), 
flatulence ( stony dullness may also be seen), burning sensation in the body, 
indigestion and intense suffering with discomfort  are the signs and symptoms of this 
disease. 
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8. Vatha Pitha ilaippu noi 
 Pain all over the body, piercing pain, fever, thirst, expectoration, tasteless, 
cough, excess flatus, burning sensation in the body, syncope, ptyalism, scanty 
micturition, black discolouration of the body, excess  coldness, dyspnoea, sneezing, 
piercing pain in stomach, lacrimation, sour taste  and dryness of the chest are the signs 
and symptoms of this disease. 
9. Vatha Kapha ilaippu noi 
 Sore throat, hoarseness of voice, fever, cough, pain all over the body, 
expectoration, weakness of the body, loss of appetite, anorexia, pallor of the body, 
atrophy of the limbs, palpitation in pulse, itching in the lower end of the bridge of the 
nose are the signs and symptoms seen in this disease. 
10. Pittha Kapha ilaippu noi 
 Excess sleep, excess laziness, fever, vomiting, sputum in vomitus, diarrhoea, 
cough and haemoptysis, odourful sputum, giddiness, depressive psychosis, thirst, 
sinusitis, shivering with cold, sputum accumulation in chest and dryness of nose are 
the signs and symptoms of this disease. 
11. Vihara ilaippu noi 
 Hallucination of sounds in the ear, pallor conjunctiva in both eyes, losing of 
stamina and strength of the body, emaciation of the body, ulceration, discharge, 
syncope, pain in the sides of the chest, haemoptysis, foul smell in the mouth and 
breath, excess appetite, burning sensation in the body, pain in the body, chillness in 
the extremities, irritation and congestion in uvula are the signs and symptoms of this 
disease. 
12. Thontha ilaippu noi 
 Change of voice, fever, cough with haemoptysis, bad odour in mouth, 
shivering, diarrhoea, syncope, blackish discolouration of tongue, aloe’s smell on the 
body, talkativeness, anuria and constipation, vomiting, dyspnoea, pungent irritation in 
throat, cough and bitterness of mouth are the signs and symptoms of this disease. 
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Curable varieties of the disease: 
 Brahma ilaippu noi, Rasa ilaippu noi, Vaishya ilaippu noi, Pitha ilaippu noi, 
and Kapha ilaippu noi are curable by medicine.  
Incurable varieties of the disease 
 Sutthira ilaippu noi, Vatha ilaippu noi, Vatha Kapha ilaippu noi, Pitha Kapha 
ilaippu noi, Vihara ilaippu noi, Thontha ilaippu noi and Vatha pitha ilaippu noi are 
incurable by treatment. 
 The above said classifications are a generalized one as stated by Yugi. Another 
type of classification is based on the organs in which the deranged life forces and 
Vayu’s are responsible for the occurrence of TB. It is as follows: 
Tuberculosis which occurs in the organs below the umbilicus 
 The tuberculosis occurs in the intestine just below the umbilicus occurs 
intestine and its allied organs. The signs and symptoms of this disease will be as that 
of bronchial tuberculosis. In addition to those, frequent loose watery motion will be 
present. Body will be very much emaciated. Distension of lower abdomen, atrophied 
extremities and shrunken face will be seen. Fever will be frequent. Many nodules will 
be seen below the skin of distended abdomen. Day by day, the distension of the 
abdomen will increase and diarrhoea also occurs. Pain in the abdomen and 
accumulation of water in peritoneal cavity as that of ascites will be present. 
Tuberculosis in the organs below the chest 
 This disease occurs in liver and kidney. The liver enlarges day by day. In the 
same manner, kidney also swells. Frequent micturition and incontinence of urine will 
be present. As in the other types of tuberculosis, here also the body will be emaciated. 
There will be unbearable pain in the lower back and in the hip. 
Tuberculosis pertaining to the skin 
 Mostly, this disease occurs in the young age or middle age group. Erythema 
nodosum will be seen in nose, jaws, toes and in hands. It will become swollen and 
ulcerated. Alternative granulation and ulceration will occur. Ulcer may become 
permanent without getting healed. 
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Tuberculosis in nasal cavity 
 Frequent obstruction in nasal cavity and sneezing, cough and rhinitis will be 
present. The defect which occurs in nose will persist for a longer duration. However, 
watery discharge will become hard as that of sputum. Sometimes, it may fall from the 
nose as a hard mass. In one or both sides of the nasal bridge, there will be ulceration 
with some swelling. This ulcer will not be reddish as other ulcers. Apart from this, the 
general signs and symptoms of the disease will continue one after the other. This 
disease occurs rarely. 
Tuberculosis in throat 
 As the sputum increases in pharynx and larynx, the tone of the voice is 
reduced. This is not easily curable. As it continues for a longer period, emaciation of 
the body occurs and other symptoms of tuberculosis will continue one after the other. 
On both sides of the pharynx, there will be swellings covered with whitish 
membranes. Ulceration and pitting will also be seen in the mass. Hoarseness of voice 
will persist for a longer duration, and it is not easily curable by any medicines. 
Tuberculosis in neck 
 Around the neck, the lymph glands will be enlarged and so the glandular 
swellings will be seen around the neck as garland. They will be painful and the 
swellings will increase in size day by day. The swellings in the neck appear first with 
pain, then they enlarge and join with one another and look like a garland in the neck. 
Mostly, this disease occurs in children. 
 Day by day, the glandular swellings will increase to a bigger round, hardened 
mass round the neck. Sometimes, they ripen and open. This ulcer will not heal easily. 
It makes the individual emaciated. Fever, cough and diarrhoea will continue, and 
finally death will occur. 
Tuberculosis of the chest 
 This disease mainly affects the lungs and spreads slowly. Body will get 
emaciated without the knowledge of the patient. Anorexia will be present. Running 
nose, mild cough with expectoration and sputum being lesser but sometimes stained 
with blood will manifest. 
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 Hoarseness of voice with sore throat, rise of temperature in the evening and 
obstruction in breathing will be seen. Pleurisy and hyper pyrexia will get associated 
with this. Sometimes, there will be severe fever; cough and emaciation will be 
present. Sometimes, intermittent fever will be present for a longer duration and then 
severe cough and expectoration to a large extent will continue. The fever will be 
present throughout the day. For some individuals, without showing any of the above 
symptoms, the strength and stamina of the body alone will be reduced day by day. 
Afterwards, cough occurs slowly and then increases. 
 For some people, Kapha fever occurs at first, and it will get decreased. 
Afterwards, fever may continue with emaciation of the body. Thus occasion of  
tuberculosis ocurrs. The other symptoms will follow one after the other afterwards. 
Tuberculosis in the axillary region: 
 This disease occurs after the age of 10-15 years. Along with the above said 
symptoms, glandular swelling will be seen in axilla. 
Tuberculosis of the joints 
 Mostly, it occurs in knees and elbow joints of children. The swelling will 
resemble the inflammation of a joint. One or more joints will be affected. The 
swelling in joints will increase slowly little by little. The swelling is due to 
accumulation of fluid in the joints. Along with this, mild fever and cachexia will be 
seen. 
 The disease may also affect the hip joint (ball  and socket joint) in which the 
upper end of the femur and ileum join together. In this disease, mostly the upper end 
of the femur will be affected. The bone in that area is putrefied and becomes 
shortened. Because of this, the leg in the affected side will be shorter than the 
unaffected leg. There will be difficulty in adduction of the affected leg. The body will 
be emaciated and also the other symptoms of tuberculosis will persist. 
Tuberculosis of the bone 
 The bones in the vertebral column from top to bottom may be affected by this 
disease. Signs and symptoms will vary according to the affected bone. 
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 When the disease occurs in the lower part of the vertebral column, 
degeneration of the bone occurs in any of the sides of the bone and so the spinal cord 
may be bent because of the strength of the bone being lost due to degeneration. 
Though there is no pain at the lesion, severe pain will occur while there are tapping 
and beating on the head. Pain will also be felt while bending. In the diseased 
condition of lumbar vertebrae, there will be shortening of leg. 
 When the disease affects the bone above that level, there will be pain in the 
buttocks and lower abdomen. When the disease affects the thoracic vertebral bones, 
there is pain in the stomach, and it also causes inability of the spine to bend forward, 
backward or sideways. The lateral curvature is called scoliosis. In potts disease or 
tuberculosis of the spine, excessive backward curvature of the dorsal spine occurs. 
This is called kyphosis. Kypho scoliosis or hibbus occurs in the thoracic spine. When 
cervical spine gets affected, head is erected and the shoulders support the head and so 
there is inability to move the head independently but its movement is possible along 
with the body. 
 In tuberculosis, sometimes the affected bone gets putrefied and pus may form. 
The pus moves through thin membranes and gets accumulated in various places 
according to the sight of the affected bone. It may be the lower part of the mouth, 
sides of the chest, or in the groins of the thigh. It will appear like abscess and may 
open.pus will come out from the opening. 
 If nerves get affected or compressed due to degenerations or putrefication of 
bones, the function of the nerves gets affected and so the organs to which the nerves 
supply also go dysfunctional. The supplying area of the nerves will have gnawing 
pain, piercing  pain and numbness. Sometimes, paraplegia may occur. Micturition will 
be difficult (inability to pass urine). Death may occur if the cervical bones get 
affected. 
Treatment of Tuberculosis: 
 This disease occurs due to increase of Kapha
 
and due to reduction in the 
strength of the seven body tissues (Udal kattukal).
 (34)
 In this condition, the Vayu in 
the body get stimulated. The stimulated Vayu cause the disease in their site of 
existence. So the main aim of the treatment of this disease should be to normalize the 
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increased life force and the other life forces which join to it. The other aim should be 
to increase the strength and stamina of the tissues debilitated in this disease. Medicine 
should be given to set right the affected Vayu also. As in this disease loss of appetite 
is also an important symptom, medicine should be given to stimulate appetite also. 
Rich diet and medicine should be given to improve the stamina of the body. Vomiting 
and diarrhoea may be induced to normalize the conditions of the life forces. Vomiting 
is needed to expel the accumulated sputum in lungs and to reduce the increased 
Kapha. For inducing vomiting, milk, ghee, oil of emetic nut (Randia dermetorum) and 
decoction of emetic nut must be given. In the same manner, oil of Tirunelveli senna 
(Cassia anciolata) may be given for inducing diarrhoea. Diet and medicines to 
stimulate appetite and to strengthen the body may be given. By these methods, the 
altered life forces will come to normal. In continuation of this, vital and powerful 
medicines like calcinated white and red powders of mercury, gold, etc., which act 
directly against the disease must be given. 
 
3.2.2 MODERN ASPECT: 
 Tuberculosis still remains one of the world’s most prevalent infectious 
diseases. We still have an incomplete knowledge to understand the nature of the 
virulence of the tubercle bacillus and the nature of the host response to the 
tuberculous infection. Neither do we have a very clear understanding of the reason for 
the rise and fall in the number of cases of tuberculosis, nor is there a general 
appreciation of the inadequacies of the public health control methods that have been 
used to combat the disease. 
The Mycobacterial World 
Scientific classification: 
   Kingdom        :  Bacteria  
  Class               :  Actinobacteria  
  Order               :  Actinomycetales 
  Suborder         :  Corynebacterineae 
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  Family             :  Mycobacteriaceae  
  Genus               :  Mycobacterium 
 Species             :  tuberculosis 
 Tubercle bacilli are non-motile, non sporing non capsulate straight or curved 
rods about 3 * 0.3 mm in size.
 [27] 
 
Mycobacterium tuberculosis is an obligate aerobe. For this reason, in the 
classic case of tuberculosis, MTB complexes are always found in the well-aerated 
upper lobes of the lungs. The bacterium is a facultative intracellular parasite, usually 
of macrophages, and has a slow generation time, 15-20 hours, and a physiological 
characteristic that may contribute to its virulence. 
Cell Wall Structure 
 The cell wall complex contains peptidoglycon, but otherwise it is composed of 
complex lipids. Over 60% of the Mycobacterial cell wall is lipid. The lipid fraction of 
MTB's cell wall consists of three major components, mycolic acids, cord factor and 
wax-D.
 [28] 
 
Mycolic acids are unique alpha-branched lipids found in cell walls of 
Mycobacterium and Corynebacterium. Mycolic acids are strong hydrophobic 
molecules that form a lipid shell around the organism and affect permeability 
properties at the cell surface.  Mycolic Acids are thought to be a significant 
determinant of virulence in MTB. Probably, they prevent attack of the mycobacteria 
by cationic proteins, lysozyme and oxygen radicals in the phagocytic granule. They 
also protect extracellular mycobacteria from complement deposition in serum. 
 Cord Factor is responsible for the serpentine cording mentioned above. Cord 
factor is toxic to mammalian cells and is also an inhibitor of PMN migration. Cord 
factor is most abundantly produced in virulent strains of MTB. 
 Wax-D in the cell envelope is the major component of Freund's complete 
adjuvant (CFA). 
 The high concentration of lipids in the cell wall of Mycobacterium 
tuberculosis has been associated with these properties of the bacterium: 
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 Impermeability to stains and dyes  
 Resistance to many antibiotics  
 Resistance to killing by acidic and alkaline compounds  
 Resistance to osmotic lysis via complement deposition  
 Resistance to lethal oxidations and survival inside of macrophages 
Metabolism of mycobacteria  
 Mycobacterium tuberculosis requires iron for essential metabolic pathways. 
Because iron is not freely available in the host, pathogens must actively 
compete for this metal to establish an infection but they must also carefully 
control iron acquisition as excess free iron can be extremely toxic.
[29] 
 The fact that iron has been known to be the key player required for its survival 
and ability to spread infection, the organism must carefully balance iron 
acquisition with iron uptake for its infectivity. Conversely, this iron 
homeostatic process could be disrupted to interfere with the survival and 
replication of this bacterium in host.
[30] 
 In mycobacteria the protein  regulates the tricarboxylic acid cycle and 
glutamate synthesis by direct binding and regulation of three enzymes that use 
α-ketoglutarate.[31] 
 The sulfate assimilation pathway of  Mycobacterium tuberculosis  is 
responsible for the biosynthesis of sulfur-containing metabolites that influence 
bacterial pathogenesis.
[32] 
 
The number of problems presented by the organism of tuberculosis. 
These problems may be discussed under four headings. 
 1. Variability 2. Virulence 3. Biochemistry and 4.Types. 
 Tissue changes in tuberculosis including formation and healing of cavity 
changes in the tissues caused by the tubercle bacillus need not be characteristic. A 
simple abscess or an area of infiltration with lymphocytes and plasma cells may be 
tuberculous in origin,
 
 especially in mucous membrane (for example, in the larynx) or 
in tubercular organs such as the kidney or epididymis. Usually, however, the 
alterations in the tissues have certain features which may be taken as typical 
characters of tuberculosis. These may be grouped into early and later changes.
[33] 
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1) Tuberculous tissue reactions may be grouped into early and late reactions. 
2) The early response to the invasion of tubercle bacilli consists of tissue 
alteration (necrosis), exudation and local cell proliferation. The last-named 
leads to infiltration with macrophages and after the acute irritation have 
subsided and after then the formation of epithelioid cells, giant cells and 
tubercles occurs. The tuberculous giant cells (of the langhans type) are, not 
infrequently, endothelial and vascular offshoots, i.e. abortive vessels.  
3) These early reactions do not occur in any particular order. One type of reaction 
may be present without traces of the others. From the very first local cell 
proliferation may occur and there is no need to postulate invisible initial stages 
of cell necrosis or leucocytic exudation. 
4) All types of early reaction may occur in any affected organ or part of organ ( 
e.g. interstitial or parenchymatous tissue) 
5) Predominate, are the type, number, virulence and chemical constitution of the 
bacillus. Other factors are the varied susceptibility of different animals and of 
different organs and tissues to tuberculous infection. 
6) Generally, in the causation of the tubercular response,  
a) The action of the bacillus as a fine particulate body, 
b) Allergy, and  
c) Specific action of certain compounds of the bacillus must be considered. 
Cell proliferation characteristic of tuberculosis was said to be elicited by 
the phosphatides of the bacillus. The application of this to human and 
experimental conditions, however, meets with difficulties. 
7) The later tissue reactions to the invasion of the tubercle bacilli are caseation, 
liquefaction, fibrosis, calcification and ossification. 
8) Caseation is tissue coagulation, consisting of 
a) Cell necrosis preceded by degenerative fat infiltration and  
b) Precipitation of fibrin and a homogenous hyaline-fibroid substance from 
the tissue fluids (vitreous degeneration). Caseation may occur rapidly and 
involve large areas simultaneously. 
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Virulence of mycobacteria 
 Mycobacterium tuberculosis (Mtb) adapts to persist in a nutritionally limited 
macrophage compartment. Lipoamide dehydrogenase (Lpd), the third enzyme (E3) in 
Mtb’s pyruvate dehydrogenase complex (PDH), also serves as E1 of peroxynitrite 
reductase/ peroxidase (PNR/P), which helps Mtb resist host reactive nitrogen 
intermediates.
 [34] 
 
Virulence  is the ability of a microbe to cause disease in a host. It can also be 
defined as the degree of pathogenicity of a microbe.  
 Virulence is caused by several factors that are encoded by the bacteria. There 
are then several different ways by which the bacteria can cause the disease. First, the 
virulence factors can induce cell adhesion to the host cell. Second, they can increase 
the colonisation of the host body and the persistence. Third, they can favour invasion 
into host cells. Fourth, the bacteria can express inhibitors of the immune response. 
Fifth, some bacteria can express toxins. 
Mycobacterium tuberculosis Virulence Factors
 [35] 
1. Secreted Factors 
 The first category is secreted factors, which are products that are exported 
outside the bacteria. They include culture filtrate proteins, such as HspX, Esat6/CFP-
10, and 19-kD 
2. Cell Surface Components  
 The cell surface components include proteins involved in synthesis of the cell 
wall. 
3. Enzymes Involved in Metabolism 
 The third category includes enzymes involved in general or cellular 
metabolism. Some of these enzymes are involved in lipid and fatty acid metabolism, 
which allows bacteria to grow on fatty acids. 
4. Transcriptional Regulators 
 The final category of virulence factors includes the transcriptional regulators. 
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Pathogenesis: 
 The portal entry of the organisms is inhalation, ingestion or inoculation. 
Inhalation is the most common route. Droplets containing MTB are released when a 
PT patient coughs. The primary site of infection depends on the mode of entry. The 
development of hypersensitivity plays a major role. T- Lymphocytes play a major role 
in conferring immunity against Mycobacterium Tuberculosis.
 [36] 
 
T- Lymphocytes play a major role in conferring immunity against 
Mycobacterium tuberculosis. Tuberculosis bacillus circulates in blood and the number 
of circulating bacteria may reach high counts in immunocompromised hosts. 
 The host reaction to the bacilli which enter is initially exudative, and later 
proliferative. Initially the exudates are composed mainly of neutrophils. Later, 
lymphokine activated macrophages accumulate and these engulf the organisms. The 
pathological hallmark of tuberculosis is the tubercle which consists of an area of 
central caseation, around which there is infiltration by epithelioid cells, giant cells, 
round cells and peripherally by fibroblasts. Several such microscopic tubercles from 
the macroscopic tubercles which are seen in affected tissues.
 [37] 
Clinical features: 
 Persistent cough, Haemoptysis, Pleural pain not associated with an acute 
illness, Spontaneous pneumothorax, Lethargy, Weight loss, Low grade evening fever 
and anorexia are the clinical features.
[38]
 Physical examination of the chest may reveal 
signs of consolidation, cavitations, collapse, fibrosis, pleural effusion or 
pneumothorax.
[39] 
As the condition proceeds the patient becomes emaciated. Cough 
with expectoration is pronounced and extreme cachexia develops (Phthisis). If left 
untreated, death occurs due to extensive disease, cachexia, intercurrent infection or 
any of the following complications.
 [40] 
Complications
 [41] 
 Pneumothorax, pleural effusion, poncet’s syndrome, secondary infection to 
cavities, pleural effusion, empyema, progressive fibrosis with dyspnea, aspergilloma, 
coexistence of apical tuberculosis with carcinoma and secondary amyloidosis  
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Investigations  
These are the following investigations are available for tuberculosis [42] 
 Pulmonary chest X-ray  
 CT 
 Bronchoscopy  
 Gastric wash 
 Transbronchial needle aspiration 
 Endoscopic Ultrasound Needle Aspiration(EUS) 
 PET 
 Abreugraph  
 Sputum analysis[43] 
 Alternative sampling 
 PCR 
 Microscopic observation drug susceptibility assay culture 
Treatment: 
First line of anti-tuberculous drug
 [44] 
 Ethambutol  
 Isoniazid  
 Pyrazinamide  
 Rifampicin  
 Streptomycin 
Second line anti-tuberculous drug: 
 Amino glycosides  e.g: amikacin (AMK), kanamycin(KM) 
 Polypeptides  e.g: capreomycin, viomycin, enviomycin  
 Fluoroquinolones e.g: ciprofloxacin, levofloxacin, moxifloxacin  
 Thioamides e.g: ethionamide, prothionamide  
 Cycloserine  
 Terizidone 
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Third line anti-tuberculous drug :
[45] 
 Rifabutin  
 Macrolides e.g.: clarithromycin  
 Linezolid  
 Thioacetazone  
 Thioridazine  
 Arginine  
 Vitamin D 
 Bedaquiline 
Classification of Anti- TB drugs according to its pharmacological actions
 [46] 
1. Tuberculocidal agents:
 
 Isoniazid 
 Streptomycin 
 Capreomycin 
 Ciprofloxacin 
 Rifampicin 
 Pyrazinamide 
 Kanamycin 
2. Tuberculostatic agents: 
 Ethambutol 
 Ethionamide 
 Thioacetazone 
 Cycloserine 
 Though these anti- tubercular drugs have more therapeutic potentials, some 
adverse effects are always reported. Nausea, vomiting  and epigastric pain, transitory 
and asymptomatic increase in hepatic enzyme levels, arthralgia, cutaneous pruritus or 
fever, psychosis, convulsive seizures, mental confusion and coma are some adverse 
effects are observed by anti-tubercular drugs.
[47] 
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Drug Resistance 
 With over eight million cases and two million deaths annually, tuberculosis 
(TB) remains a major cause of morbidity and mortality worldwide. Recently, it has 
been shown that multidrug-resistance (MDR) is the most important cause for 
mortality in patients with tuberculosis. Drug resistance is considered one of the main 
threats for tuberculosis control. Diabetes mellitus, prior tuberculosis treatment and 
intravenous drug use were risk factors for drug-resistant disease. The association 
between diabetes and drug-resistant TB should be further explored. Identifying 
clinical predictors of drug resistance can allow prompt identification of patients at risk 
for drug-resistant TB.
 [48] 
 
Drug-resistant tuberculosis (TB) is a worldwide threat and constitutes an 
unparalleled challenge for disease control. Treatment of such patients is more 
complex, less effective, more toxic and much more expensive than treatment of 
patients infected with drug-susceptible TB strains. 
 International studies have identified various risk factors for drug-resistant TB; 
these include previous TB treatment, poor adherence to treatment regimens, 
inadequate regimens and positive smear result at the end of the second and third 
month of treatment. In addition of these programmatic factors, patients characteristics 
such as HIV co-infection, alcohol abuse and younger age are also believe to influence 
the drug resistance. 
 For instance, high prevalence levels of drug resistance have been found among 
HIV patients. In recent years, drug-resistant TB has emerged, largely due to delays in 
treatment, gaps in treatment protocol and ineffective or delayed drug-susceptibility 
testing. Multi-drug resistant tuberculosis (MDR-TB) is defined by the resistance of 
the bacillus to the most powerful TB drugs, Isoniazid and rifampicin, while 
extensively drug-resistant TB (XDR-TB) is also resistant to some second line drugs 
 So there is an urgent need of a drug which acts in MDR-TB and XDR-TB 
also. 
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3.3 PHARMACEUTICAL REVIEW 
Purification processes in Siddha system (Suddhiseithal) 
The process of detoxification or purification of the drug is called 
‘Suddhiseithal’ in Siddha medical terminology. 
Nature has created innumerable plant, herbs, metals, poisonous substances, 
minerals, salts and other organic substances.  Siddha had selected such of those things 
which can render relief to innumerable ailments of mankind suffered. Any matter in 
nature has to be utilized for medicinal purposes, the properties which may cause bad 
effects should be neutralized or eliminated. That’s why every raw drug used in Siddha 
medicine is purified before preparing it as a medicine. 
Purification 
The exact part of the herb which has been described should alone be taken for 
medicine. There should not be other impurities like mud, sand or any such thing. If it 
is green leaf, dried or decomposed and insects infected leaves should be eliminated. 
Care should be taken in identifying the herbs properly. 
As a general rule, when anything is subjected to be processed by using heat, 
soaking either alone or with some other substances, some chemical reaction may take 
place.  In these process impurities, toxins would be eliminated and the substances 
become purified. Hence some of the poisonous herbs which are purified by using 
heat. 
Importance of purification 
The drugs when subjected to heat like roasting or soaked in liquids undergoes 
some chemical reactions. Such as oxidation of toxic substances to non-toxic 
substances, elimination of certain poisonous chemicals to non- poisonous substances. 
In these ways not only the toxicity, impurities are removed but also enhance the 
potency of the drugs.  
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Mathirai :
[49] 
 The ingredients should be purified first and pounded into a fine powder and 
then macerated with the prescribed juices or liquid one after the other in their order. 
Each time it must be ground till it becomes waxy in consistency does not adhere to the 
fingers or mortar and pestle; finally it must be made into pills as prescribed size and 
dried in shade.  
Other names : Kuligai, Urundai 
Rule of tablet preparation 
 Before preparing mathirai, the raw drugs required are powdered separately and 
then mixed to attain homogeneity, then ground together until it reaches waxy 
in consistency. 
 The fine paste which does not stick to the mortar should be considered as the 
right consistency for rolling pills. 
 If any of the preparation of pills, if mercury and sulphur are the key 
ingredients, mercury should be ground first and sulfur is added to it and 
ground and further continued. 
 In case of inclusion of hard raw drugs, they should be ground first; the reason 
behind this if hard substances are added to smooth substances, they will not be 
ground finely.  
 Croton seeds if included can be grinded at the last: because croton on grinding 
releases oil; if added early the effect of medicine will be suppressed, so it 
should be added finally. 
 Aromatic substances like camphor, lac, musk  are added just before 24 
minutes the paste reaches waxy consistency. 
 The paste should not adhere to the mortar nor does it adhere to the pestle. 
Storage 
They should be stored in well stopper glass vials, with relevant labels and 
instructions.  
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Shelf life of medicines 
Medicines can be classified into internal and external medicines. They are 
each in 32 types. Mathirai comes under the category of internal medicines. The shelf 
life of medicines indicates the potency of medicines. The medicines even though 
seems to be fresh is not efficacious after sometime. So the medicines should not use 
after certain period. 
The shelf life of mathirai, 
As per Siddha literature Agamarunthu padal in Gunapadam Thathu-seevam text 
 
“உனர்சூப ணம்஧ிட்டு யடகம் வயண் வணய்஥ரன்கி 
னுனிர்ப௄ன்று திங்கவ஭ண்வணய் 
யிபலிடுப௃ னர்ந்தநரத்  திசபகடுகு ஧க்குயம் 
 ......................................................................... 
வகரள்஭ரறு  ணநரபரண்டு..........................................  
- குண஧ரடம் தரது சீயம் யகுப்பு 
 
 From above the quote the shelf life of Mathirai is 1 year. But according to 
Ayush guidelines the shelf life is 2 years.  
 Traditional tests for Mathirai  
 Characters  
 Non sticky on rolling 
 No cracks over the surface after drying 
 Shall be rolled uniformly over the plane surface.  
Based on these characters the drug is assessed as the appropriate one for medication. 
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Table 1: Testing parameters for Mathirai - AYUSH guidelines 
S.No Tests 
  1 Description, Colour, Odour 
  2 Weight Variation 
  3 Disintegration Time (Not more than 15 minutes) 
  4 Identification TLC/ HPTLC/GLC 
  5 Assay 
  6 Test for heavy/toxic metals 
       Mercury 
       Arsenic 
       Cadmium 
       Lead 
    7 Microbial Contamination 
      Total Bacterial count 
      Total Fungal count 
     8 Test for specific pathogen 
      Escherichia coli 
      Salmonella species 
      Pseudomonas aeruginosa 
      Streptococcus aureus 
    10 Test for aflatoxins B1, B2, G1, G2 
 Modern Aspect of the formulation: 
Tablet (Pill)- Mathirai 
A tablet is a pharmaceutical dosage form, it otherwise called as caplet. 
Medicinal tablets are called as "pills". Originally "pills" referred specifically to a soft 
mass rolled into a ball shape, rather than a compressed powder.
 [50]
 
As per Indian Pharmacopeia 2007 defined the tablets are solid dosage forms 
each containing a unit dose of one or more medicaments. They are anticipated for oral 
route. A tablet consists an active medicament with excipents which are in powder 
form are compressed or pressed into a solid dosage form. About two third drugs 
prescribed are in solid dosage form and tablets include half of them. 
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Classifications: 
 As per IP2007 tablets are majorly classified into following categories (Indian 
pharmacopoeia 2007) 
1. Uncoated Tablets: 
This type of tablets contains single layer or more than one layer tablet 
consisting of active ingredient with the excipents, no additional cover is applied on to 
it after the compression. 
2. Coated Tablets: 
 Coated types of tablets have an additional coating layer on it after the tablet 
was compressed, the coating layer of tablets formed with sugar, gums, resins, inactive 
or insoluble fillers,  plasticisers, polyhydric alcohols, waxes. 
3. Dispersible Tablets:  
 These are the film coated or uncoated tablets because a uniform dispersion 
when suspended in water 
4. Effervescent Tablets:  
 These type of tablets which are uncoated and are planned to be dissolved and 
produce an dispersion before they are administered the dissolution is achieved by the 
reaction between an organic acid and bicarbonate which produce CO2, thus produced 
CO2 will disintegrate the tablet so which dissolves in the solution to produce an 
suspension which was rapidly absorbed. 
5. Modified-release Tablets:  
 These types of tablets are the coated or uncoated tablets which are designed in 
such a way that the rate or location of the active ingredient released is modified. It 
includes enteric coated tablets, prolong release tablet or delay release tablet. 
A) Enteric-coated Tablets:  
 These are also called as gastro resistant tablets as they resistant to the gastric 
juices; these are formulated by coating the tablet with anionic polymer of 
methylacrylic acid and their esters or by coating with cellulose acetyl pthylate. 
 E.g: erythromycin, NSAIDS 
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B) Prolonged- release Tablets:  
These types are otherwise called as sustain release tablets or extended release 
tablets was formulated in such a way that the active ingredient is released for a 
prolong duration of time and is available in systemic circulation after administration. 
C) Delayed-release Tablets:  
This dosage form was planned to release the drug after some time  or after the 
tablet has passed one part of the GIT into another. All enteric coated tablets are type 
of delayed action tablet but all delayed action of tablets was not enteric or not 
intended to produce enteric action. 
6. Soluble Tablets: 
These are coated or uncoated tablets which are planned to dissolve in water 
before they are administered. 
7.  Tablets for Use in the Mouth: 
These are the tablet formulations which are planned to be show local action in 
the buccal cavity. These include buccal tablet, Sublingual Tablets and Troche or 
lozenges. Buccal tablets are placed in between the cheek and gingival. Sublingual 
tablets are placed below the tongue E.g: glyceryl trinitrate. 
8. Tablets for other routes of administration:  
These include implantable tablets and vaginal tablet. These are inserted in to 
the rectum or vagina for their local or systemic action. 
Tablet Ingredients: 
A tablet consist of active medicament with excipents which are in powder form 
are compressed or pressed into a solid dosage form. In addition to active ingredients, 
tablet contains a number of inert materials known as additives or excipents.
 [51] 
 Diluent  
 Binder and adhesive  
 Disintegrents  
 Lubricants and glidants  
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 Colouring agents  
 Flavouring agents  
 Sweetening agents  
1. Diluent:   
Diluents are fillers are used to make bulk of the tablet when the drug dosage 
itself was inadequate to produce the bulk these are used. Secondary reason is to 
provide better tablet properties such as improve cohesion, to permit use of direct 
compression manufacturing or to promote flow. 
2. Binders and Adhesives: 
 These materials are added either dry or wet form granules or to form cohesive 
compacts for directly compressed tablet. Ex: Acacia, tragacanth Solution for 10-25% 
Concentration. 
3. Disintegrents:  
It added to the tablet formulations to facilitate its breaking or disintegration, 
when it contact in water in the GIT.  Example: Starch 5-20% of tablet weight.  
Super Disintegrents: Swells up to ten fold within 30 seconds when contact 
with water. Example: Crosscarmellose cross-linked cellulose. 
4. Lubricant and Glidants:  
Lubricants are planned to prevent adhesion of the tablet materials to the 
surface of dies and punches, reduce inter particle friction and may improve the rate of 
flow of the tablet granulation Example: Lubricants - Stearic acid, stearic acid salt - 
Stearic acid. 
5. Coloring agent:  
The use of colors and dyes in a tablet has three purposes:  
 Masking  off colour drugs  
 Product Identification  
 Production of more elegant product  
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 All coloring agents must be approved and certified by FDA. 
1. Flavoring agents: 
For chewable tablet- flavour oil are used  
2. Sweetening agents: 
 For chewable tablets: Sugar, Mannitol. Saccharine (artificial): 500 times 
sweeter than sucrose. 
Advantages: 
 These are very easy and handy to use. 
 As these are unit dosage form fixed dose was administered. 
 Modified drug release rate and duration of tablets be able to increase their 
therapeutic effect and increase the patient compliance by reducing the 
frequency of drug administration. 
 These are cost-effective dosage forms when compared to other dosage forms 
 The physical, microbial and chemical stability of tablet are superior to other 
dosage forms. 
Disadvantages: 
 The systemic availability of the drug depends on many physiological factors 
 The onset of action was lesser when compared to Intra Venous route. (except 
sublingual tablets) 
 Geriatric and infants cannot swallow the tablets easily. 
 
3.4 PHARMACOLOGICAL REVIEW 
 PHARMACOLOGICAL SCREENING OF ANTI- TUBERCULOSIS
 [52] 
a. Absolute concentration method (LJ) 
 A stock solution of active compound was prepared in sterile DMSO. 
Subsequent dilutions were made with sterile distilled water and aseptically added to 
the Lowenstein-Jensen media to give the desired final concentrations viz: 12.5, 25, 50, 
100, 200 and 400g/ml. 
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Preparation of Lowenstein-Jensen medium: 
Ingredients of L-J medium 
Potassium dihydrogen orthophosphate  
Anhydrous (KH2PO4)     : 2.4 gm 
Magnesium sulphate anhydrous   : 0.24 gm 
Magnesium citrate    : 0.6 gm 
L-Asparagine      : 3.6 gm 
Glycerol (reagent grade)    : 12.0 ml 
Malachite green, 2% solution   : 20.0 ml 
Distilled water     : To 600 ml 
The ingredients were dissolved in 50ml-distilled water; after dissolving, 
glycerol malachite green solution was added and made up to 600ml with distilled 
water. This solution was autoclaved at 121
o
 C for 30 minutes to sterilize and cooled to 
room temperature and the solution was stored in refrigerator. 
Preparation of egg solution 
 The clean hen eggs were broken individually into round bottomed flask and 
shaken vigorously to obtain homogenous solution and filtered through sterile gauze 
into a measuring cylinder upto 1 litre.  
Preparation of complete medium 
 The following ingredients were aseptically pooled in a large, sterile flask and 
mixed well. 
Mineral salt solution   : 600ml 
Homogenized egg solution   : 1000 ml 
(From 25-30 eggs, depending on size) 
 The active compound was mixed with the complete medium at different 
dilutions to obtain the necessary final concentrations. The medium was distributed in 
6-8ml volumes in sterile universal containers and the caps tightly closed and 
inspissation is done at 85-90
o
C for 50 minutes without delay to prevent sedimentation 
of heavier ingredients. After inspissation, the medium was incubated at 37
o
C for 24 
hours to check for sterility.  
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Standard bacterial suspension 
 Bacterial suspension was prepared by adding approximately 4 mg moist 
weight of a representative sample of the bacillary mass. Two to three loopfuls of 
culture were taken using the inoculation loop with 3mm internal diameter and added 
to 0.2 ml of sterile distilled water in a 7mm bottle containing twelve (2-3mm dia.) 
glass beads. To prepare a uniform suspension, 0.8ml sterile water was added and 
shaken. This suspension contained approx. 4mg/ml of the organism. For absolute 
concentration method this standard suspension was used. 
 Ten microliter of suspension was inoculated on both compound containing and 
compound free LJ slopes (control). Standard strain M. tuberculosis H37Rv was set up 
with each batch of test as assay control. These slopes were incubated at 37C and read 
after 28 days. The MIC was calculated as the lowest concentration that inhibited 
growth (defined as 20 colonies or more on compound containing medium) as 
described in the Standard operating procedure of Mycobacteriology, NIRT (2010).  
 
BRONCHODILATOR ACTIVITY IN ANIMAL MODELS 
In vitro methods 
Spasmolytic activity on guinea pigs isolated tracheal chain  
 The isolated tracheal chain of guinea pigs can be used for testing compounds 
which inhibit bronchospasm. It detects sympathomimetic, H1-histamine receptor 
antagonistic properties of test drug. 
Methodology  
 Guinea pig of either sex weighting between 300-500 gm are sacrificed using 
ether anesthesia. The entire trachea is dissected out and cut into individual rings. 
Twelve to fifteen rings are tied together with silk threads and mounted in the organ 
bath containing Krebs-Henseleit solution and maintained at 37
o
C, under a tension of 
0.5 gm and gassed with carbon. Isometric contractions are recovered via a strain 
gauge transducer on a polygraph. Forty five minutes are allowed for equilibration 
before the addition of the spasmogens. The following spasmogens used Histamine, 
Carbachol, LTC4 or LTD4. It takes about 10-12 min for reaching the contraction to a 
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maximum. At this standard and test drugs are administered. The bronchial response is 
allowed to plateau and recorded. The tissue is rinsed thoroughly and the control 
contractions are induced again by adding spasmogens. The percent inhibition of 
spasmogens induced contractions is calculated. From dose response curve ED50 is 
calculated.
 [53]
 
Isolated Frog Rectus Abdominis Muscle Preparation: 
 A frog is pithed and laid out on frog dissection board. The skin of the anterior 
abdominal wall is cut by a midline incision which is extended laterally up to the 
anterior aspects of the limbs. This exposes the flat whitish muscle of the anterior 
abdominal wall from their pubic origin to their sternal insertion. The two recti are 
removed and placed in frog ringer solution in a shallow dish. They are carefully 
cleaned and one of them is trimmed to the desired size and mounted in an organ bath 
of 5ml capacity, at room temperature, aerated with oxygen. For recording purposes, 
an isotonic lever with a sideways writing point is used tangential to the smoked drum, 
balanced for a tension of 2.5gm with an extra load of 1gm on the long arm. A 
standard solution of Ach is added to the bath and a slow contraction is recorded on the 
slow moving drum for exactly 90 seconds. The drum is stopped and the bath fluid is 
replaced by fresh Frog-Ringer. An extra 1gm load is used to extend the muscle to its 
original length.
 [54] 
In vivo methods 
Histamine induced bronchospasm in guinea pig 
 Guinea pigs subjected to inhibition of aerosols containing histamine or other 
bronchospasm inducing agents, exhibits the symptoms of asphyxiating convulsions 
resembling acute attack of bronchial asthma. These challenging agents are 
administered in the form of aerosols through a nebulizer to individual guinea pigs 
placed in a histamine chamber. The initial symptoms are increased frequency of 
breathing, forced breathing and finally asphyxiating convulsions. The occurrence of 
these symptoms can be delayed by antagonistic drugs and bronchodilators. Pre-
convulsion time is noted as the end point. 
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Methodology  
 Male guinea pigs weighing around 400 gm are used in groups of 8-10 animals. 
The animals are treated with test / standard drugs orally or subcutaneously. The 
animals are then placed in the standard Histamine chamber, 30 minutes after the 
administration of drug and exposed to an aerosol of 0.1 % solution of histamine 
dihydrachloride through a nebulizer. Time required for the onset of asphyxiating 
convulsions is recorded. The animal is immediately withdrawn from the inhalation 
box and placed in a well-ventilated area for revival from the convulsions. This method 
has been further improvised using an ultra-sound nebulizer which provides the steady 
exposure to histamine solution at a pre-determined rate. Percent of increase of pre-
convulsion time is calculated from the average values of treated and control groups of 
guinea pigs. ED50 values denoting 50% increase in the pre-convulsion time can also 
be calculated. Histamine aerosol exposure is a very commonly used and dependable 
method for screening the bronchodilator activity of novel compound.
 [55]
     
Egg albumin induced anaphylaxis in guinea pig: 
 Guinea pig was sensitized by two intra peritoneal injections of 0.5 ml and 10% 
w/v solution of egg albumin at 48 hours interval. After sensitization, the animals were 
divided into two groups. Animals of group I received 0.5% CMC and named as 
control group. Animals of group II received ethanolic extract trial drug (500 mg/kg. 
once daily) dissolved in distilled water for 14 days. On day 14, two hours after 
treatment, the animals were challenged with 0.5 ml of 2% w/v solution of egg 
albumin into the saphenous vein. Guinea pigs were observed for onset of symptoms 
such as dyspnoea and cyanosis, duration of persistence of symptoms and mortality.
 [56] 
 
ANTI-HISTAMINE ACTIVITY: 
Effects of diphenhydramine in experimentally produced asthma in guinea pigs 
Aim  
 To demonstrate the antagonistic effects of diphenhydramine against histamine 
induced bronchospasm in the guinea pig. 
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Principle  
 Guinea pig is very sensitive to histamine. When guinea pig is exposed to 
histamine vapour it exhibits bronchospasm, difficulty in breathing and convulsion. 
These effects of histamine are mediated through the action of histamine on H1 
receptors. Diphenhydramine is a H1 receptors blocker. Therefore, diphenhydramine 
prevents the bronchospasm induced by histamine. 
Equipments and other materials required 
 Histometer, stop watch, disposable needle and syringes. 
Animal: Guinea pigs 
Drug solutions required 
1. Normal saline  
2. Diphenhydramine 5 mg/ml 
3. Histamine diphosphate 30µg/ml 
Procedure  
 Select 4 guinea pigs having body weight between 250-350 gm, fast the guinea 
pigs for 12 hours before the experiment. Divide the guinea pigs into 2 groups of 2 
animals each. Weigh the guinea pigs in each group and mark them for identification. 
Administer the drug solutions as Group I: Normal saline 1 ml/kg, Group II: 
Diphenhydramine 5 mg/kg. After one hour place each guinea pig in histamine 
chamber and replace the cover. With the help of compressor, spray a finely atomized 
mist of histamine diphosphate from nebulizer in both compartments. Using a stop 
watch record the time of histamine administration. Observe the signs of respiratory 
distress and the animal falling on its side and record the observations.
 [57] 
Isolated Guinea Pig Ileum 
      Overnight fasted guinea pigs of either sex weighing 400-600gms were sacrificed 
using cervical dislocation method. The lower most 10cm of ileum was removed from 
the abdomen and placed in a shallow dish containing warm Triode solution. Ileum 
lumen was cleaned by passing through warm 0.9% saline and then segments about 
one inch in length, were made. The mesenteric attachment and blood etc. were 
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carefully cleaned and tissues was mounted in a thermostatically controlled Dale’s 
organ bath containing 20ml Triode’s solution under basal tension of 500mg. The 
composition of solution is Nacl, 137; Cacl2, 1.8; Kcl, 2.7; glucose, 5.55; NaHco3, 
11.9; Mgcl2, 1; NaH2Po4, 0.4. The solution was continuously bubbled with air. The 
responses to drug were recorded on a student physiography using isotonic transducer, 
which exerted a basal tension equivalent to 500mg load tissue. The issue was allowed 
to equilibrate for 30 minutes, during which, the bathing solution was changed at every 
10 minutes. Increasing concentration of histamine were added to the bath and the 
control cumulative concentration-response curve was constructed.
[58]
 
LATERAL RESEARCH: 
1. Cinnamomum verum / Cinnamomum zeylanicum: 
ANTIMICROBIAL ACTIVITY: 
The objective of this work was to evaluate the chemical composition, 
antimicrobial and antileishmanial activities of Cinnamomum zeylanicum, Origanum 
vulgare and Curcuma longa essential oils. Chemical analysis was performed by gas 
chrromotography- mass spectrometry. Antimicrobial activity was performed by disk 
diffusion and minimum inhibitory concentration  (MIC) test. 
Result: 
 The disc diffusion method showed that the largest halo was observed 
for Cinnamomum zeylanicum  essential oil against Escherichia coli, 
whereas Origanum vulgare and Curcuma longa essential oil presented better 
inhibition against Staphylococcus aureus. 
[59] 
 
ANTI-HYPERTENSIVE ACTIVITY: 
Background: 
 The aqueous extract of the stem bark of  Cinnamomum zeylanicum possesses 
anti- hypertensive and vasodilatory properties. The present work investigates the 
acute and chronic antihypertensive effects of the methanol extract of Cinnamomum 
zeylanicum stem bark (MECZ) in L-NAME-induced hypertensive rats. 
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Results 
 Acute intravenous administration of Cinnamomum zeylanicum extract (5, 10 
and 20 mg/kg) to L-NAME-induced hypertensive rats provoked a long-lasting 
decrease in blood pressure. Mean arterial blood pressure decreased by 12.5%, 26.6% 
and 30.6% at the doses of 5, 10 and 20 mg/kg, respectively. The MECZ also 
significantly lower the plasma level of triglycerides (38.1%), total cholesterol (32.1%) 
and LDL-cholesterol (75.3%) while increasing that of HDL-cholesterol (58.4%) with 
a significant low atherogenic index (1.4 versus 5.3 for L-NAME group).
[60]
 
2. Cinnamomum tamala: 
ANTIDIABETIC, ANTIOXIDANT AND ANTIHYPERLIPIDEMIC 
ACTIVITIES : 
Abstract 
The ethanol extract of the leaf of Cinnamomum  tamala was used for 
investigating its effect against diabetes using a rat model. Oral administration of the 
ethanol extract of Cinnamomum tamala resulted in significant decrease in the blood 
glucose levels, glycosylated haemoglobin, thiobarbituric acid reactive substances and 
serum lipids in diabetic rats under investigation. It was also observed that the oral 
administration of ethanol extract of Cinnamomum tamala significantly decreased the 
levels of reduced glutathione and superoxide dismutase in the hepatic and renal 
tissues of alloxan-induced diabetic rats. These results provided evidence for the 
antidiabetic, antioxidant and antihyperlipidemic effects of the ethanol extract 
of Cinnamomum tamala when administered orally. 
Result: 
Preliminary phytochemical screening of the aqueous (hot and cold) and 
ethanol extracts of Cinnamomum tamala showed the presence of various 
phytoconstituents including alkaloids, steroids, terpenoids, flavonoids and saponins. 
Several phenolics, flavonoids and alkaloids possess marked antidiabetic activities. 
Saponins possessed hypocholesterolemic and antidiabetic properties. The presence of 
these phytochemicals supports the claim for the medicinal uses of Cinnamomum 
tamala as potent antioxidant and hypoglycaemic agent.
[61]
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3. Eleterria cardamomum: 
ANTI-ANXIETY ACTIVITY: 
Abstract: 
The present study aims to evaluate the efficacy of Eleterria cardamomum 
methanolic extract on anxiety-like behavior in a rat model of PTSD. Adult 
male Wistar rats (200–250 gm) were used in this study. The rats underwent single 
prolonged stress (SPS) or control and intraperitoneally received either saline or 
different dosages (200, 400, and 800 mg/kg) of  Eleterria cardamomum methanolic 
extract before and after stress sessions.  Findings demonstrated that Eleterria 
cardamomum  methanolic extract, particularly at the dose of 400 mg/kg, significantly 
(P < 0.05) improved anxiety-like behavior in a rat model of PTSD, as examined by 
the open field, elevated plus-maze, and rotarod tests. Administration of  Eleterria 
cardamomum methanolic extract after stress might help to prevent the formation of 
anxiety-like behavior in the animals.
[62]
  
4. Piper longum: 
IMMUNOMODULATARY AND ANTITUMOR ACTIVITY: 
Abstract: 
Alcoholic extract of the fruits of the plant Piper longum and its component 
piperine was studied for their immunomodulatory and antitumor activity. Alcoholic 
extract of the fruits was 100% toxic at a concentration of 500 μg/ml to Dalton’s 
lymphoma ascites (DLA) cells and 250 μg/ml to Ehrlich ascites carcinoma (EAC) 
cells.  
Result: 
Administration of Piper longum extract and piperine increased the total WBC 
count to 142.8 and 138.9%, respectively, in Balb/c mice. The number of plaque 
forming cells also enhanced significantly by the administration of the extract 
(100.3%) and piperine (71.4%) on 5th day after immunization. Bone marrow 
cellularity and α-esterase positive cells were also increased by the administration 
of Piper longum extract and piperine.
[63] 
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5. Karkandu (Sugar candy): 
ANTIOXIDANT ACTIVITY: 
Abstract: 
Phenolic compounds in sugar cane (Saccharum officinarum L.) juice were 
identified and quantified by analytical high performance liquid chromatography and 
photodiode array detection, showing the predominance of flavones (apigenin, 
luteolin and tricin derivatives), among flavonoids and of hydroxycinnamic, caffeic 
and sinapic acids, among phenolic acids, representing a total content of around 
160 mg/L. A tricin derivative was present in the highest proportion (>10% of the 
total). 
Result: 
The phenolic extract obtained from sugar cane juice showed a protective 
effect against in vivo MeHgCl intoxication and potent inhibition of ex vivo 
lipoperoxidation of rat brain homogenates, indicating a potential use for beneficial 
health effects and/or therapeutic applications.
[64]
 
6. Dried dhiratchai ( Vitis vinifera): 
Abstract 
Six raisin grape cultivars and 10 new raisin grape selections were analyzed for 
antioxidant activity (ABTS assay) and for total and individual phenolic compounds. 
Samples were freeze–dried and values are reported on a dry weight basis. Antioxidant 
activity across the 16 samples ranged from 7.7 to 60.9 μmol Trolox/g DW, with A95-
27 exhibiting the greatest activity. Total phenolic content, determined in gallic acid 
equivalents using the Folin–Ciocalteau assay, ranged from 316.3 to 1141.3 mg gallic 
acid/100 g DW and was strongly correlated (r = 0.990) with antioxidant results. 
Concentrations of individual phenolics were determined by HPLC. trans-Caftaric acid 
was the predominant compound in all samples. A95-15 contained the lowest 
concentration (153.5 μg/g DW) of caftaric acid, while Fiesta contained the highest 
concentration (598.7 μg/g DW). Selections A56-66, A95-15, and A95-27 had much 
higher levels of catechin (86.5–209.1 μg/g DW) and epicatechin (126.5–365.7 μg/g 
DW) than the other samples.
[65]
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7.  Adhimathuram (Glycyrrhiza glabra): 
Objective:  
                        To study the anticonvulsant activity of ethanolic extract of Glycyrrhiza 
glabra in albino rats and mice. Methods: The anticonvulsant activity of ethanolic 
extract of roots and rhizomes of Glycyrrhiza glabra (10, 30, 100 and 500 mg/kg, i.p.) 
in mice was assessed using maximum electroshock seizure (MES) test and 
pentylenetetrazol (PTZ) using albino mice. The lithium-pilocarpine model of status 
epilepticus was also used to assess the anticonvulsant activity in rats. Results: The 
ethanolic extract of  Glycyrrhiza glabra did not reduce the duration of tonic hindleg 
extension in the MES test even in the dose of 500 mg/kg. However, the extract 
significantly and dose-dependently delayed the onset of clonic convulsions induced 
by pentylenetetrazol. The dose of 100 mg/kg afforded protection to all animals. The 
extract also protected rats against seizures induced by lithium-pilocarpine. 
Conclusion: The ethanolic extract of  Glycyrrhiza glabra inhibits PTZ and lithium-
pilocarpine-induced convulsions but not MES-induced convulsions. Anticonvulsant 
Glycyrrhiza glabra lithium-pilocarpine MES PTZ A.
[66] 
8. KARCHURKAI (Phoenix dactilifera): 
                    Phoenix dactylifera exhibits potent anti-oxidative properties both in 
vitro and in vivo. This allows the fruit to prevent depletion of intrinsic protection from 
oxidative cell damage and assist these defense systems in reducing cell damage. 
Macroscopically, this mechanism may be relevant to the prevention of various 
adverse drug events common to chemotherapy including hepatotoxicity, 
nephrotoxicity, gastrotoxicity and peripheral neuropathy. While such effects have 
only been studied in small animal systems, research suggests a potential application to 
more complex mammalian systems and perhaps a solution to some problems of 
chemotherapy in hepato-compromised and nephro-compromised patients. 
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   4. MATERIALS AND METHODS 
4.1 PREPARATION OF THE DRUG 
Selection of drug 
The trial drug “Thirijadhathi mathirai” will be prepared as per Siddha literature 
“Anubava vaithiya devaragasiyam.” 
Ingredients 
 Lavangapattai (Cinnamomum verum ) - ½ thola (6g)  
 Lavangapathiri ( Cinnamomum tamala) - ½ thola (6g) 
 Elakkai ( Eletteria cardamomum)  - ½ thola (6g) 
 Thipilli (Piper longum)   - 2 thola (24g) 
 Karkandu ( Sugar candy)   - 4 thola (48g) 
 Dried Dhiratchai ( Vitis vinifera)  - 4 thola (48g) 
 Adhimadhuram (Glycyrrhiza glabra)  - 4 thola (48g) 
 Karchurakai (Phoenix dactilifera)  - 4 thola (48g) 
Collection of the drugs 
The crude drugs such as Lavangapattai, Lavangapathiri, Elakkai, Thipilli, 
Karkandu, Dried dhiratchai, Adhimathuram, Karchurakai were procured from 
Ramasamy  Chettiar Raw Drug Stores at Chennai. 
Identification and Authentication  
 All raw drugs were identified and authenticated by the experts from Gunapadam 
department (Pharmacology) at Government Siddha Medical College, Arumbakkam, 
Chennai. 
 The specimen samples of the identified raw drugs were preserved in the 
laboratory of P.G Gunapadam for future references. 
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PURIFICATION OF THE DRUGS: 
[67] 
 All the drugs were purified as per the Siddha literature. 
Lavangapattai 
 Dried in sunlight.   
Lavangapathiri 
 Dried in sunlight. 
Elakkai 
 Roasted in the pan and outer skin was removed.  
Thipilli 
 Soaked in 60 ml lime juice until the juice is evaporates.
  
Karkandu 
 Clean the dust particles. 
Dried dhiratchai 
 Clean the dust particles and allowed it to dry. 
Adhimathuram 
 Cleaned and cut into small pieces and dried. 
Karchurkai   
 The seed is removed and dried in sunlight. 
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Method of preparation 
 All the ingredients were purified. The purified drugs are crushed into fine powder 
separately, then mixed together. The ingredients are triturated with honey in a stone 
mortar until it reaches the waxy consistency. Then rolled into tablet in size of siru nellikai 
allavu (5gm), dried in shade and labeled as Thirijadhathi mathirai (TM). 
Preservation 
 The medicine was preserved in a clean, air tight container. 
Administration of the drug 
Form of the medicine  : Chewable tablet 
Route of administration : Enteral 
Dose    : 1 to 2 tablets 
Time of administration : Twice a day 
Adjuvant   : Hot water. 
Indication   : Kabakasam, Thummal, Suram. 
 
Fig. 9 Ingredients of Thirijadhthi mathirai 
                                   
              
                                               
       
 
 
                  Lavangapattai                                                Lavangapathiri 
     (Cinnamomum verum)              ( Cinnamomum tamala) 
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4.2 STANDARDISATION OF THE DRUG 
World Health Organization (WHO) has appreciated the importance of medicinal 
plants for public health care. The process of evaluating the quality and purity of herbal  
drugs by means of various parameters like physical, chemical and biological observation 
is called standardization. Standardization of the this drug comes under the following 
categories 
 Physico-chemical analysis 
 Phyto chemical analysis 
 Bio chemical analysis 
ORGANOLEPTIC EVALUATION 
The Organoleptic characters of the sample were evaluated which include 
evaluation of the formulation by its colour, odour, size etc. 
1. Colour examination:  
Ten tablets were taken into watch glasses and positioned against white back 
ground in white tube light. Its colour was observed by naked eye and wrote in results. 
2. Odour examination:  
 Ten numbers of tablets were smelled individually. The time interval among two 
smelling was kept two minutes to overturn the effect of previous smelling. Odour of TM 
was noted in results table.  
 
4.2.1 PHYSICO-CHEMICAL INVESTIGATION
 
Physico‐chemical studies like total ash, water insoluble ash, acid Insoluble ash, 
loss on drying at 105°C and pH were done at, Tamilnadu Dr. M.G.R. Medical University, 
Chennai. 
1. pH value 
 Potentiometrically pH value was determined by a glass electrode and a pH meter. 
The pH of the TM was written in results column.  
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2.  Loss On Drying: 
An accurately weighed 1gm of Thirijadhadhi mathirai formulation was taken in 
a tarred glass bottle. The crude drug was heated at 105
0
C for 6 hours in an oven till a 
constant weight. The Percentage moisture content of the sample was calculated with 
reference to the shade dried material. 
3. Determination of total ash: 
Weighed accurately 2gm of Thirijadhadhi  mathirai formulation was added in 
crucible at a temperature 600
0
C in a muffle furnace till carbon free ash was obtained. It 
was calculated with reference to the air dried drug.  
4. Determination of acid insoluble ash: 
Ash above obtained, was boiled for 5min with 25ml of 1M Hydrochloric acid and 
filtered using an ash less filter paper. Insoluble matter retained on filter paper was washed 
with hot water and filter paper was burnt to a constant weight in a muffle furnace. The 
percentage of acid insoluble as was calculated with reference to the air dried drug. 
5. Determination of water soluble ash: 
Total ash 1gm was boiled for 5min with 25ml water and insoluble matter 
collected on an ash less filter paper was washed with hot water and ignited for 15min at a 
temperature not exceeding 450
0
C in a muffle furnace. The amount of soluble ash is 
determined by drying the filtrate.  
6. Determination of water soluble Extractive: 
5gm of air dried drug, coarsely powered Thirijadhadhi mathirai was macerated 
with 100ml of distilled water in a closed flask for twenty-four hours, shaking frequently. 
The Solution was filtered and 25 ml of filtrate was evaporated in a tarred flat bottom 
shallow dish, further dried at 100
0
 C and weighted. The percentage of water soluble 
extractive was calculated with reference to the air dried drugs.   
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7. Determination of alcohol soluble extractive: 
1 gm of air dried drugs, coarsely powdered Thirijadhadhi mathirai was 
macerated with 20 ml. alcohol in closed flask for 24 hours. With frequent shaking. It was 
filtered rapidly taking precaution against loss of alcohol. 10ml of filtrate was then 
evaporated in a tarred flat bottom shallow dish, dried at 100
0
C and weighted. The 
percentage of alcohol soluble extractive was calculated with reference to air dried 
drug.
[68] 
 
4.2.2 PHYTO CHEMICAL EVALUATION  
Phytochemical are chemical compounds that are naturally present in plants. 
Phytochemical screening of the plant gives a vast idea about the chemical constituents 
present in the drug.  
The preliminary phytochemical screening test was carried out for each extracts of 
Thirijathathi mathirai as per the standard procedure.
[69] 
1. Detection of alkaloids: 
Extracts were dissolved individually in dilute Hydrochloric acid and filtered. 
a) Dragendroff’s Test:  
Filtrates were treated with Dragendroff‟s reagent (solution of Potassium Bismuth 
Iodide). Formation of red precipitate indicates the presence of alkaloids. 
2. Detection of carbohydrates: 
Extracts were dissolved individually in 5 ml distilled water and filtered. The 
filtrates were used to test for the presence of carbohydrates. 
a) Fehling’s Test: 
 Filtrates were hydrolyzed with dilute HCL, neutralized with alkali and heated 
with Fehling‟s A & B solutions. Formation of red precipitate indicates the presence of 
reducing sugars. 
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3. Detection of glycosides:  
Extracts were hydrolyzed with dil. HCl  and then subjected to test for glycosides. 
a) Modified Borntrager’s Test:  
Extracts were treated with Ferric Chloride solution and immersed in boiling water 
for about 5 minutes. The mixture was cooled and extracted with equal volumes of 
benzene. The benzene layer was separated and treated with ammonia solution. Formation 
of rose-pink color in the ammonical layer indicates the presence of anthranol glycosides. 
4. Detection of saponins 
a) Froth Test: Extracts were diluted with distilled water to 20ml and this was shaken in a 
graduated cylinder for 15 minutes. Formation of 1 cm layer of foam indicates the 
presence of saponins. 
5. Detection of phenols Ferric Chloride Test: 
Extracts were treated with 3-4 drops of ferric chloride solution. Formation of 
bluish black color indicates the presence of phenols. 
6. Detection of tannins Gelatin Test: 
The extract is dissolved in 5 ml of distilled water and 2 ml of 1% solution of 
Gelatin containing 10% NaCl is added to it. White precipitate indicates the presence of 
phenolic compounds. 
7. Detection of Flavonoids 
a) Alkaline Reagent Test: Extracts were treated with few drops of sodium hydroxide 
solution. Formation of intense yellow color, which becomes colorless on addition of 
dilute acid, indicates the presence of flavonoids. 
8. Detection of proteins  
a) Xanthoprotein Test: The extracts were treated with few drops of conc. Nitric acid. 
Formation of yellow color indicates the presence of proteins. 
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9. Detection of aminoacids 
a) Ninhydrin Test:To the extract, 0.25% w/v ninhydrin reagent was added and boiled for 
few minutes. Formation of blue color indicates the presence of amino acid. 
10. Detection of diterpenes Copper Acetate Test: 
Extracts were dissolved in water and treated with 3-4 drops of copper acetate 
solution. Formation of emerald green color indicates the presence of diterpenes. 
11. Gum and Mucilage: 
To 1ml of extract add 2.5ml of absolute alcohol and stirring constantly. Then the 
precipitate was dried in air and examine for its swelling properties. Swelling was 
observed that will indicate presence of gum and mucilage. 
12. Test for Quinones: 
Extract was treated with sodium hydroxide blue or red precipitate indicates the 
presence of Quinones. 
13. Test for Fixed oils and Fats: 
a. Spot test: A small quantity of extract is pressed between two filter papers. Oil stain on 
the paper indicates the presence of fixed oils. 
The Preliminary phytochemical studies of aqueous extract of Thirijathathi 
mathirai were done using standard procedures. The results were presented in tables. The 
present study reveals that the bioactive compounds were present in all the extracts of 
Thirijathathi mathirai. 
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TLC/ HPTLC finger print studies  
HPTLC finger printing was carried out as per the reference.
 [70] 
Preparation of spray reagent-vanillin-sulphuric acid reagent 
Vanillin (1g) was dissolved in ice cold ethanol (95ml).  Add to 5ml of cooled 
concentrated sulphuric acid. Ice was added and stirred well. The solution was stored in 
refrigerator.   
Chromatographic conditions  
Instrument    : CAMAG (Switzerland). 
Sample Applicator   : Camag Linomat - IV applicator with N2 gas flow. 
Photo documentation System : Digi store - 2 documentation system with Win Cat 
& video scan software. 
Scanner   : Camag HPTLC scanner - 3 (030618), Win Cats - IV.  
Development Chamber  : Camag HPTLC 10X10, 10 X 20 twin trough linear 
                                                 Development chamber. 
Quantity applied  : 5, 10 µl for extracts and 5 µl for standards 
Stationary phase   : Aluminum plate pre-coated with silica gel 60(E. Merck) 
Plate thickness   : 0.2 mm. 
Mobile Phase : For Chloroform extract - Toluene: Ethyl acetate (9:1) and 
ethanol extract - Toluene: Ethyl acetate (1:1).   
Scanning wavelength  : 575 nm 
Laboratory condition  : 26 ± 5
o
C and 53 % relative humidity 
The plate was developed up to a height of 8 cm, air dried, spots were observed 
under the UV light at 254 and 366 nm. Finally the plates were derivatized using vanillin-
sulphuric acid reagent heated at 105° till colour spots appeared.  
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4.2.3 BIO-CHEMICAL ANALYSIS
[70] 
The bio-chemical analysis was done to identify the acid and basic radicals present 
in the TM. 
Preparation of extract 
 5gm of TM was taken in a 250 ml clean beaker and 50 ml of distilled water was 
added, boiled well and allowed to cool and filtered in a 100 ml volumetric flask and made 
up to 100 ml with distilled water.  
Preliminary Basic and Acidic radical studies  
Test for basic radicals 
1. Test for Potassium 
 To a pinch of the TM , 2 ml of sodium nitrate and 2 ml of cobalt nitrate solution in 
30% glacial acetic acid was added and observed for the presence of yellow precipitate. 
2. Test for Calcium 
To 2 ml of TM extract, 2 ml of 4% ammonium oxide solution was added and 
observed for the formation of white precipitate. 
3. Test for Magnesium: 
To 2ml of TM extract, drops of sodium hydroxide solution was added and 
watched for the appearance of white precipitate. 
4. Test for Ammonium: 
To 2ml of TM extract few ml of Nessler's reagent and excess of sodium hydroxide 
solution are added for the appearance of brown colour. 
5. Test for Sodium 
Hydrochloric acid was added with a pinch of the TM, made as paste and 
introduced into the blue flame of Bunsen burner and observed for the appearance of 
intense yellow colour.  
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6. Test for Iron (Ferrous) 
The TM extract,  was treated with Conc. HNO3 and ammonium thiocyanate and 
waited for the appearance of blood red colour.   
7. Test for Zinc 
To 2 ml of the TM extract drops of sodium hydroxide solution was added and 
observed for white precipitate formation.  
8. Test for Aluminium 
To the 2m1 of the TM extract sodium hydroxide was added in drops and changes 
are noted.  
9. Test for Lead 
To 2 ml of TM extract 2ml of potassium iodide solution was added and noted for 
yellow coloured precipitate.  
10. Test for Copper 
a. A pinch of TM was made into a paste with con. Hcl in a watch glass and 
introduced into the non-luminous part of the flame and noted for blue colour appearance. 
b. To 2 ml of TM extract excess of ammonia solution was added and observed for 
the appearance of blue coloured precipitate.  
11. Test for Mercury 
 To 2m1 of the TM extract sodium hydroxide solution was added and noted for 
yellow precipitate formation.  
12. Test for Arsenic   
 To 2 ml of the TM extract 2ml of sodium hydroxide solution was added and 
brown or red precipitate formation was noted.  
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Test for acid radicals 
1. Test for Sulphate 
 To   2 ml of the TM extract, 5% of barium chloride solution was added and 
observed for the appearance of white precipitate.  
2. Test for Chloride 
 The TM extract was treated with silver nitrate solution and observed for the 
appearance of white precipitate. 
3. Test for Phosphate 
         The TM extract was treated with ammonium molybdate and conc. HNO3 and 
observed for the appearance of yellow precipitate. 
4. Test for Carbonate 
        The TM extract was treated with conc.Hcl and observed for the appearance of 
effervescence. 
5. Test for Fluoride & Oxalate: 
To 2ml of TM extract 2ml of dil.acetic acid and 2ml calcium chloride solution 
was added and heated and watched for cloudy appearance. 
6. Test for Nitrate: 
 To 1 gm of the TM, copper turnings was added and again conc.H2SO4 was added, 
heated and the test tube was tilted vertically down  and observed for any changes. 
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4.2.4 MICROBIAL ACTIVITY 
BACTERIAL LOAD: 
[71] 
AGAR- WELL DIFFUSION METHOD 
PRINCIPLE 
The antimicrobials present in the samples are allowed to diffuse out into the 
medium and interact in a plate freshly seeded with the test organisms. The resulting zones 
of inhibition will be uniformly circular as there will be a confluent lawn of growth. The 
diameter of zone of inhibition can be measured in millimeters. 
MATERIALS REQUIRED 
1. Muller Hinton Agar Medium (1 L) 
The medium was prepared by dissolving 33.8 g of the commercially available 
Muller Hinton Agar Medium (MHI Agar Media) in 1000ml of distilled water. The 
dissolved medium was autoclaved at 15 lbs pressure at 121°C for 15 minutes. The 
autoclaved medium was mixed well and poured onto 100mm petriplates (25-30ml/plate) 
while still molten. 
2. Nutrient broth (1L) 
One litre of nutrient broth was prepared by dissolving 13 g of commercially 
available nutrient medium (HI Media) in 1000ml distilled water and boiled to dissolve 
the medium completely. The medium was dispensed as desired and sterilized by 
autoclaving at 15 lbs pressure (121ºC) for 15 minutes. 
3. Streptomycin (standard antibacterial agent, concentration: 10mg / ml) 
4. Culture of test organisms; growth of culture adjusted according to McFarland 
Standard, 0.5% 
1. Escherichia coli (ATCC 25922) 
2. Staphylococcus aureus (ATCC 25923) 
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3. Pseudomonas aeroginosa (ATCC 27853)  
4. Klebsiella pneumoniae (ATCC 13883) 
PROCEDURE 
Petriplates containing 20ml Muller Hinton Agar Medium were seeded with 
bacterial culture of Escherichia coli, Pseudomonas aeroginosa, Klebsiella pneumoniae 
and Staphylococcus aureus (growth of culture adjusted according to McFarland Standard, 
0.5%). Wells of approximately 10mm was bored using a well cutter and different 
concentrations of sample such as 250μg/mL, 500μg/mL and 1000μg/mL were added. The 
plates were then incubated at 37°C for 24 hours. The antibacterial activity was assayed by 
measuring the diameter of the inhibition zone formed around the well (NCCLS, 1993). 
Streptomycin was used as a positive control. 
 
ANTI-FUNGAL LOAD:
[71] 
AGAR- WELL DIFFUSION METHOD  
PRINCIPLE: 
In order to access the biological significance and ability of the sample, the 
antifungal activity was determined by Agar well diffusion method. The antifungals 
present in the samples are allowed to diffuse out into the medium and interact in a plate 
freshly seeded with the test organisms. The resulting zones of inhibition will be 
uniformly circular as there will be a confluent lawn of growth. The diameter of zone of 
inhibition can be measured in millimeters. 
MATERIALS REQUIRED: 
1. Potato Dextrose Agar Medium (1 L) 
The medium was prepared by dissolving 39 gm of the commercially available 
Potato Dextrose Agar Medium (HiMedia) in 1000ml of distilled water. The dissolved 
medium was autoclaved at 15 lbs pressure at 121°C for 15 minutes. The autoclaved 
medium was mixed well and poured onto 100mm petriplates (25-30ml/plate) while still 
molten. 
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2. Clotrimazole (standard antifungal agent, concentration: 10mg / ml) 
3. Culture of test organisms; growth of culture adjusted according to McFarland 
Standard, 0.5% 
 Aspergillus niger (ATCC 16404)  
PROCEDURE: 
Potato Dextrose agar plates were prepared and overnight grown species of fungus, 
Aspergillus niger were swabbed. Wells of approximately 10mm was bored using a well 
cutter and samples of different concentrations such as 250μg/mL, 500μg/mL and 
1000μg/mL were added. The zone of inhibition was measured after overnight incubation 
at room temperature and compared with that of standard antimycotic (Clotrimazole) 
(NCCLS, 1993). 
 
4.2.5 SOPHISTICATED INSTRUMENTAL ANALYSIS 
FT IR - Fourier Transform Infra-red Spectroscopy 
[72] 
 
 
 
 
 
                     
            
 
    
                                              Fig. 11. FTIR INSTRUMENT 
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FTIR (Fourier Transform Infra-red Spectroscopy) is a sensitive technique 
particularly for identifying organic chemicals in a whole range of applications although it 
can also characterize some inorganics. Examples include paints, adhesives, resins, 
polymers, coatings and drugs. FTIR is an effective analytical instrument for detecting 
functional groups. 
Applications: 
 Quantative scans 
 Qualitative scan solids, liquids, gasess 
 Organic samples, inorganic samples 
 Unknown identification  
 Impurities screening 
 Formulation 
 Pharmaceuticals  
Principle:  
Spectrophotometric tests are commonly used in the Identification of chemical 
substances and quantification of polymorphic forms. The test procedures are applicable to 
substances that absorb IR radiation. The IR absorption spectrum of a substance compared 
with that obtained concomitantly for the corresponding reference standard / reference 
substance provide conclusive evidence of the identity of the substance being tested.  
 Recording Infrared spectrum of a solid as a disc (as per USP ‹197K›):  
 Triturate about 1 to 2 mg of the substance to be examined with 300 to 400 mg, 
unless otherwise specified, of finely powdered and dried potassium bromide. 
If the substance is a hydrochloride it is preferable to use potassium chloride.  
 Carefully grind the mixture and spread it uniformly in a suitable die.  
 Submit it to the pressure of about 800 mPa (8 tons/cm2).  
 Examine the disc visually and if any lack of uniform transparency is observed, 
reject the disc and prepare again.  
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 Record the spectrum between 4000 to 650 cm-1 unless otherwise specified in 
individual standard test procedure.  
 When sample and standard are measured for concordance, the transmittance 
obtained at the start of the scan range, should not deviate by more than 10% 
between them (For eg. If the standard shows a transmittance of 75%, the 
sample transmittance can be between 65% and 85%). 
FT-IR was the most advanced and the major advantage was its 
 Speed 
 Sensitivity 
 Mechanical Simplicity 
 Internally Calibrated   
 
 
 
 
 
 
 
                         
 
                                         
 
Fig. 12.FTIR MECHANISM 
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SEM (SCANNING ELECTRON MICROSCOPE)
[73] 
         
 
 
 
 
 
 
 
                                          
 
                 Fig. 13 SEM INSTRUMENT 
Definition: 
Scanning Electron Microscopy (SEM), also known as SEM analysis or SEM 
microscopy, is used very effectively in microanalysis and failure analysis of solid 
inorganic materials. Scanning electron microscopy is performed at high magnifications, 
generates high-resolution images and precisely measures very small features and objects. 
SEM analysis applications 
The signals generated during SEM analysis produce a two-dimensional image and 
reveal information about the sample including: 
External morphology (texture) 
 Chemical composition (when used with EDS) Orientation of materials making up 
the sample 
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The EDS component of the system is applied in conjunction with SEM analysis to: 
 Determine elements in or on the surface of the sample for qualitative information 
 Measure elemental composition for semi-quantitative results 
 Identify foreign substances that are not organic in nature and coatings on metal 
SEM Analysis with EDS – qualitative and semi-quantitative results 
Magnification  – from 5x to 300,000x 
Sample Size – up to 200 mm (7.87 in.) in diameter and 80 mm (3.14 in.) in height 
Materials analyzed – solid inorganic materials including metals and minerals. 
The SEM analysis process 
Scanning Electron Microscopy uses a focused beam of high-energy electrons to 
generate a variety of signals at the surface of solid specimens. In most SEM microscopy 
applications, data is collected over a selected area of the surface of the sample and a two-
dimensional image is generated that displays spatial variations in properties including 
chemical characterization, texture and orientation of materials. The SEM is also capable 
of performing analyses of selected point locations on the sample. This approach is 
especially useful in qualitatively or semi-quantitatively determining chemical 
compositions, crystalline structure and crystal orientations. 
The EDS detector separates the characteristic X-rays of different elements into an 
energy spectrum and EDS system software is used to analyze the energy spectrum in 
order to determine the abundance of specific elements. A typical EDS spectrum is 
portrayed as a plot of X-ray counts vs. energy (in keV). Energy peaks correspond to the 
various elements in the sample. Energy Dispersive X-ray Spectroscopy can be used to 
find the chemical composition of materials down to a spot size of a few microns and to 
create element composition maps over a much broader raster area. Together, these 
capabilities provide fundamental compositional information for a wide variety of 
materials, including polymers. In scanning electron microscope high-energy electron 
beam was focused through a probe towards PP. Variety of signals was produced on 
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interaction with the surface of the sample. This results in the emission of electrons or 
photons and it was collected by an appropriate detector. 
The types of signal produced by a scanning electron microscope include:  
 Secondary electrons 
 Back scattered electrons 
 Characteristic x-rays light 
 Specimen current 
 Transmitted electrons. 
This gives the information about the sample and it includes external morphology, texture, 
its crystalline structure, chemical composition and it displays the shape of the sample.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                              Fig. 14 SEM MECHANISM 
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ICPOES (INDUCTIVELY COUPLED PLASMA OPTIC EMISSION 
SPECTROMETRY) 
             
  
 
  
 
 
 
 
 
 
 
                                      Fig. 15 ICP-OES INSTRUMENT 
Manufacturer: Perkin Elmer 
Model:  Optima 5300 DV ICP-OES Inductively Coupled Plasma Spectrometer (ICP) 
Principle: 
An aqueous sample was converted to aerosols via a nebulizer. The aerosols are 
transported to the inductively coupled plasma which was a high temperature zone (8,000– 
10,000ºC). The analysts are heated (excited) to different (atomic and/or ionic) states and 
produce characteristic optical emissions (lights). These releases are separated based on 
their respective wavelengths and their strengths are measured (spectrometry). The 
intensities are proportional to the concentrations of analyses in the aqueous sample. The 
quantification was an external multipoint linear standardization by comparing the 
emission intensity of an unknown sample with that of a standard sample. Multi-element 
calibration standard solutions are prepared from single and multi element primary 
standard solutions. With respect to other kinds of analysis where chemical speciation was 
relevant (such as the concentration of ferrous iron or ferric iron), only total essential 
concentration was analysed by ICP-OES.
 [74] 
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Application: 
The analysis of major and minor elements in solution TM. 
Objectives: 
 Determine elemental concentrations of different metals. 
 Learn principles and operation of the ICP-OES instrument 
 Develop and put on a method for the ICP-OES sample analysis 
 Enhance the instrumental conditions for the analysis of different elements 
 Probes the outer electronic structure of atoms  
Mechanism:  
In plasma emission spectroscopy (OES), a TM solution was presented into the 
core of inductively coupled argon plasma (ICP), which generates temperature of 
approximately 8000°C. At this temperature all elements become thermally excited and 
emit light at their characteristic wavelengths. This light was collected by the spectrometer 
and passes through a diffraction grating that serves to resolve the light into a spectrum of 
its essential wavelengths. Within the spectrometer, this deflected light was then collected 
by wavelength and amplified to yield an strength of  measurement that can be converted 
to an elemental concentration by comparison with standardization values.
[75] 
The Inductively coupled plasma optical emission spectrometric (ICP-OES) 
analysis was done in  IIT MADRAS, and Chennai-36 using Perkin Elmer Optima 5300 
DV. 
 
     
  
 
 
 
 
 
Fig. 16 ICP-OES MECHANISM 
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Sample preparation: 
Inductively Coupled Plasma Spectroscopy techniques are the so-called "wet" 
sampling methods whereby TM are introduced in liquid form for analysis. 
100 mg TM was occupied in a clean, dry test tube. To this, 3 ml Nitric acid was 
added and mixed well and allowed for few minutes untill the reactions were completed. 
And then, 25 ml of Refined water, was added to prepare digested solution. The digested 
TM solution was shifted into plastic containers and labeled properly. It was completed in 
Bio-chemistry lab, Govt. Siddha Medical College, Chennai-106 
 
4.2.6 TOXICOLOGICAL STUDIES 
ACUTE ORAL TOXICITY – OECD GUIDELINES - 423  
 Acute toxicity study was carried out as per OECD guideline (Organization for 
Economic Co - operation and Development, Guideline-423  
 The experimental protocol was approved by the institutional ethical committee  
(IAEC) under CPCSEA (IAEC approved number: 05/32/PO/RE/S/01/CPCSEA 
dated 12/10/2018) 
 These studies were conducted in C.L. Baid Metha College of Pharmacy, 
Thuraipakkam, and Chennai. 
PRINCIPLE:  
 It is the principle of the test that based on a stepwise procedure with the use of a 
minimum number of animals per step, sufficient information is obtained on the acute 
toxicity of the test substance to enable its classification. The substance is administered 
orally to a group of experimental animals at one of the defined doses. The substance is 
tested using a stepwise procedure, each step using three animals of a single sex. Absence 
or presence of compound-related mortality of the animals dosed at one step will 
determine the next step, i.e. no further testing is needed,  dosing of three additional 
animals with the same dose − dosing of three additional animals at the next higher or the 
next lower dose level. The method will enable a judgement with respect to classifying the 
test substance to one of a series of toxicity classes. 
[76] 
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METHODOLOGY: 
Selection of animal species:  
 The preferred rodent species are mouse and  rat, although other rodent species 
may be used. Healthy young adult animals of commonly used laboratory strains should 
be employed. Females should be nulliparous and non-pregnant. Each animal at the 
commencement of its dosing should be between 8 and 12 weeks old and its weight should 
fall in an interval within ± 20 % of the mean weight of any previously dosed animals.  
 
Housing and feeding conditions:  
 The temperature in the experimental animal room should be 22ºC (+3ºC). 
Although the relative humidity should be at least 30% and preferably not exceed 70% 
other than during room cleaning the aim should be 50-60%. Lighting should be artificial, 
the sequence being 12 hours light, 12 hours dark. For feeding, conventional laboratory 
diets may be used with an unlimited supply of drinking water. Animals may be group-
caged by dose, but the number of animals per cage must not interfere with clear 
observations of each animal.  
Preparation of animals:  
 The animals are randomly selected, marked to permit individual identification and 
kept in their cages for at least 5 days prior to dosing to allow for acclimatization to the 
laboratory conditions.  
Preparation of doses:  
 In general test substances should be administered in a constant volume over the 
range of doses to be tested by varying the concentration of the dosing preparation. Where 
a liquid end product or mixture is to be tested however, the use of the undiluted test 
substance, i.e. at a constant concentration, may be more relevant to the subsequent risk 
assessment of that substance, and is a requirement of some regulatory authorities. In 
either case, the maximum dose volume for administration must not be exceeded. The 
maximum volume of liquid that can be administered at one time depends on the size of 
the test animal.  
 In rodents, the volume should not normally exceed 1ml/100g of body weight: 
however in the case of aqueous solutions 2 ml/100g body weight can be considered. With 
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respect to the formulation of the dosing preparation, the use of an aqueous solution/ 
suspension/ emulsion is recommended wherever possible, followed in order of preference 
by a solution/ suspension/ emulsion in oil (e.g. corn oil) and then possibly solution in 
other vehicles. For vehicles other than water the toxicological characteristics of the 
vehicle should be known. Doses must be prepared shortly prior to administration unless 
the stability of the preparation over the period during which it will be used is known and 
shown to be acceptable.  
EXPERIMENT PROCEDURE:  
Administration of doses:  
THIRIJADHATHI MATHIRAI suspended in 2% CMC with uniform mixing and 
was administered to the groups of wistar Albino rats in a single oral dose by gavage using 
a feeding needle. Animals were fasted prior to dosing. Following the period of fasting, 
the animals were weighed and then the test substance was administered. After the 
substance has been administered, food was withheld for a further 3-4 hours. The principle 
of laboratory animal care was followed. Observations were made and recorded 
systematically and continuously observed as per the guideline after substance 
administration. The visual observations included skin changes, mobility, aggressiveness, 
sensitivity to sound and pain, as well as respiratory movements. They were deprived of 
food, but not water 16-18 hours  prior to the administration of the test suspension. 
Finally, the number of survivors was noted after 24 hours and these animals were then 
maintained for a further 14 days and observations made daily. The toxicological effect 
was assessed on the basis of mortality.  
Number of animals and dose levels:  
 Three animals are used for each step. The dose level used as the starting dose was 
selected from one of four fixed levels, 5, 50, 300 and 2000 mg/kg body weight. The 
starting dose level was most likely to produce mortality in some of the dosed animals. 
The available information suggests that mortality is likely at the highest starting dose 
level 300 mg/kg body weight, so the trial or limit test was conducted. The time interval 
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between treatment groups is determined by the onset, duration  and severity of toxic 
signs.  
Limit test:  
 The limit test is primarily used in situations where the experimenter has 
information indicating that the test material is likely to be toxic, i.e., having toxicity even 
below regulatory limit doses. A limit test at one dose level of 50 mg/kg body weight was 
carried out with three animals per step. The test substance-related mortality was not 
produced in animals, so further testing at the next lower level need not be carried out.  
 
OBSERVATIONS:  
 Animals were observed individually after dosing at least once during the first 30 
minutes, periodically during the first 24 hours, with special attention given during the 
first 4 hours and daily thereafter, for a total of 14 days, except where they need to be 
removed from the study and humanely killed for animal welfare reasons or are found 
dead. It should be determined by the toxic reactions, time of onset and length of recovery 
period and may thus be extended when considered necessary. The times at which signs of 
toxicity appear and disappear are important, especially if there is a tendency for toxic 
signs to be delayed. All observations are systematically recorded with individual records 
being maintained for each animal. Observations include changes in skin, fur, eyes and 
mucous membranes and also respiratory, circulatory, autonomic and central nervous 
system, somatomotor activity and behavior pattern. Attention was directed to 
observations of tremors, convulsions, salivation, diarrhea, lethargy, sleep and coma. The 
principles and criteria summarized in the Humane Endpoints Guidance Document taken 
into consideration. Animals found in a moribund condition and animals showing severe 
pain or enduring signs of severe distress was humanely killed. When animals are killed 
for humane reasons or found dead, the time of death should be recorded. 
Body weight:  
 Individual weight of animals was determined before the test substance was 
administered and at least weekly thereafter. Weight changes was calculated and recorded. 
At the end of the test surviving animals were weighed and humanely killed.  
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Pathology:  
 All the test animals were subjected to gross necropsy. All gross pathological 
changes were recorded for each animal. Microscopic examination of organs showing 
evidence of gross pathology in animals surviving 24 or more hours also was considered.  
DATA AND REPORTING:  
 All data were summarized in tabular form showing for each test group the number 
of animals used, the number of animals displaying signs of toxicity, the number of 
animals found dead during the test or killed for humane reasons, time of death of 
individual animals, a description and the time course of toxic effects and reversibility and 
necropsy findings.  
 
Test substance and Vehicle:  
  In order to ensure the uniformity in drug distribution in the medium the 
suspension was made by mixing THIRIJADHATHI MATHIRAI with 2% CMC solution 
and it was found suitable for dose accuracy.  
 
Justification for choice of vehicle: 
The vehicle selected as per the standard guideline is pharmacologically inert and 
easy to employ for new drug development and evaluation technique.  
 
Test animals and Test conditions:  
 Female Wistar Albino rats (more than 100 gms) were obtained from the animal 
house of King Institute of Preventive Medicine, Guindy, Chennai and maintained in the 
animal laboratory of C.L.Baid Metha college of Pharmacy,Chennai.  All the animals were 
kept under standard environmental condition (23±2°C).  The animals had free access to 
water and standard pellet diet (Sai meera foods, Bangalore). Rats were deprived of food 
but not water (16-18 hours) prior to administration of the test drug. The principles of 
laboratory animal care were followed and the Department‟s ethical committee approved 
the use of the animals and the study design. 
[77] 
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REPEATED DOSE 28-DAYS SUB-ACUTE ORAL TOXICITY STUDY OF PPR 
ON WISTAR ALBINO RATS (OECD – 407 GUIDELINES): 
Test Substance  : THIRIJADHATHI MATHIRAI 
Animal Source : Animal house of King Institute of Preventive      
medicine                           
Animals   : Male and Female Wistar Albino rats  
Age    : More than 8 weeks 
Acclimatization  : Seven days prior to dosing. 
Veterinary examination : Prior to and at the end of the acclimatization    
period.   
Identification of animals : By cage number, animal number and individual 
marking on fur. 
Diet : Pelleted feed supplied by Sai meera foods Pvt Ltd, 
Bangalore 
Water : Aqua guard portable water in polypropylene 
bottles ad libitum. 
Housing & Environment : The animals were housed in Polypropylene cages 
provided with bedding of husk. 
Housing temperature : Between 20 to 24°C,  
Relative humidity  :  Between 30% and 70%, 
Air changes   :  10 to 15 per hour  
Dark and light cycle  : Each of 12 hours. 
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Justification for Dose Selection: 
 The results of acute toxicity studies in wistar Albino rats indicated that 
THIRIJADHATHI MATHIRAI was nontoxic and no behavioural changes was observed 
upto the dose level of 300 mg/kg body weight. On the basis of the results of acute toxicity 
study, the doses selected for the study were15mg/kg (x), 30mg/kg (5x) and 60 mg/kg 
(10x) body weight. The oral route was selected for use because the oral route is 
considered to be a proposed therapeutic route.
[78] 
Preparation and administration of dose:  
THIRIJADHATHI MATHIRAI at three doses respectively was suspended in 2 ml 
of 2% CMC in distilled water. It was administered to animals at the dose levels of 15, 30 
and 60 mg/kg. The test substance suspensions were freshly prepared every day for 28 
days. The control animals were administered vehicle only. Administration was by oral 
(gavage), once daily for 28 consecutive days. 
METHODOLOGY 
Randomization, Numbering and Grouping of Animals: 
 Ten rats (Five Male and Five Female) were in each group randomly divided into 
four groups for dosing up to 28 days. Animals were allowed acclimatization period of 7 
days to laboratory conditions prior to the initiation of treatment. Each animal was fur 
marked with picric acid. The females were nulliparous and non-pregnant. 
OBSERVATIONS: 
Experimental animals were kept under observation throughout the course of study 
for the following: 
 Body Weight:  
Weight of each rat was recorded on day 0, at weekly intervals throughout the 
course of study and at termination to calculate relative organ weights. From the data, 
group mean body weights and percent body weight gain were calculated.   
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Clinical signs:  
All animals were observed daily for clinical signs. The time of onset, intensity 
and duration of these symptoms, if any, were recorded. 
Mortality:  
All animals were observed twice daily for mortality during entire course of study. 
Functional Observations:  
At the end of the 4
th
 week exposure, „sensory reactivity‟ to graded stimuli of 
different types (auditory, visual and proprioceptive stimuli), „motor reactivity‟ and „grip 
strength‟ were assessed. 
Laboratory Investigations:  
Following laboratory investigations were carried out on day 29 in animals at 
fasting over-night. Blood samples were collected from orbital sinus using sodium heparin 
(200IU/ml) for Blood chemistry and potassium EDTA (1.5 mg/ml) for Haematology as 
anticoagulant. Blood samples were centrifuged at 3000 r.p.m. for 10 minutes. On 28th 
day of the experiment, 24 hours urine samples were collected by placing the animals in 
the metabolic cage with free access to tap water but no feed was given.  
 The urine was free from fecal contamination. Toluene is used as a preservative 
while collecting the sample. The sediments present in the urine were removed by 
centrifugation and the collected urine was used for biochemical estimations. On 29th day, 
the animals were fasted for approximately 18 hours, then slightly anesthetized with ether 
and blood samples were collected from the retro-orbital plexus into two tubes: one with 
EDTA for immediate analysis of haematological parameters, the other without any 
anticoagulant and was centrifuged at 4000 rpm at 4 °C for 10 minutes to obtain the 
serum. Serum was stored at 20 °C until analyzed for biochemical parameters. 
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Haematological Investigations:  
Blood samples of control and experimental rats was analyzed for hemoglobin 
content, total red blood corpuscles (RBC), white blood corpuscles (WBC) count and 
packed cell volume (PCV).  
Biochemical Investigations:  
Serum was used for the estimation of biochemical parameters. Samples of control 
and experimental rats were analyzed for protein, bilirubin, urea, BUN, creatinine, 
triglyceride, cholesterol and glucose levels was carried using standard methods. Activities 
of glutamate oxaloacetate transaminase/ Aspartate aminotransferase (GOT/AST), 
glutamate pyruvate transaminase/ Alanine amino transferase (GPT/ALT) and alkaline 
phosphatase were estimated as per the colorimetric procedure.  
Histopathology:  
Histopathological investigation of the vital organs was done. The organ pieces (3-
5µm thick) of the highest dose level of 400 mg/kg were preserved and were fixed in 10% 
formalin for 24 hours and washed in running water for 24 hours. Samples were 
dehydrated in an auto technicon and then cleared in benzene to remove absolute alcohol.  
Embedding was done by passing the cleared samples through three cups containing 
molten paraffin at 50°C and then in a cubical block of paraffin made by the “L” moulds. 
It was followed by microtome and the slides were stained with Haematoxylin-eosin.   
The organs included heart, kidneys, liver and spleen of the animals were 
preserved they were subjected to histopathological examination. 
Statistical analysis:  
Findings such as clinical signs of intoxication, body weight changes, food 
consumption, hematology and blood chemistry were subjected to One-way ANOVA 
followed by Dunnet‟s multicomparision test using a computer software programme 
GRAPH PAD 8.1 version. 
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4.2.7 PHARMACOLOGICAL STUDIES: 
EVALUATION OF ANTI- TUBERCULOSIS ACTIVITY: 
Mycobacterial strains 
 Three Mycobacterial strains, viz., standard strain of M. tuberculosis H37Rv, 
clinical were used for this study. This strain was grown and maintained on Lowenstein 
Jensen (L-J) medium in the Centre for drug discovery and development, Sathyabama 
Institute for Science and Technology, Chennai, Tamil Nadu, India. 
Anti-Mycobacterial activity using Luciferase Reporter Phage assay 
Antitubercular activity is studied against standard laboratory strain 
Mycobacterium tuberculosis  H37Rv by adopting  Lusiferase reporter phage assay. About 
350µL of G7H9 broth supplemented with 10% albumin dextrose complex and 0.5% 
glycerol was taken in cryovials and added with 50µL of crude extract in order to get the 
final concentration of 250µg/mL and 500µg/mL. One hundred microliter of 
Mycobacterium tuberculosis cell suspension was added to all the vials. DMSO (1%) was 
also included in the assay as solvent control. All the vials were incubated at 37ºC for 4 
hours. After incubation, 100µL from each vial was transferred to luminometer cuvette. 
About 100µL of D-luciferin was added and relative light unit (RLU) was measured in 
luminometer. RLU reduction by 50% or more when compared to control was considered 
as having antitubercular activity.
[79] 
 
EVALUATION  OF  BRONCHODILATOR  ACTIVITY: HISTAMINE  
INDUCED  BRONCHOCONSTRICTION  IN  GUINEA  PIG: 
Overnight fasted guinea  pigs  were  divided  into  six  groups  each  containing  6 
animals.   
 Group I was treated as control,   
 Group II received standard drug Salbutamol (2 mg/kg).   
 Group III, IV THIRIJADHATHI  MATHIRAI (200 and 400mg/kg).  
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All the doses were given orally once a day for 5 days. Prior to drug treatment each 
animal was placed in the histamine chamber and exposed to 0.2 % histamine aerosol. The 
pre convulsive time (PCT) was determined from the time of exposure to onset of 
convulsions. As soon as the PCT were noted, the animal were removed from the chamber 
and placed in fresh air. Group 2 received Salbutamol. These  animals  were  again  
subjected  to  histamine  aerosol  after  1hour of  drug  administration  and  PCT  was 
determined.  The protection offered by treatment was calculated by using the formula
1, 2
.  
Percentage Protection = (1 - T1/T2) X 100    Where,  
T1 = the mean of PCT before administration of test drugs.  
T2 = the mean of PCT after administration of test drugs.
[80,81] 
EVALUATION OF ANTI-HISTAMINE ACTIVITY: 
ANTI- HISTAMINE  AND  ACETYLCHOLINE  INDUCED  BRONCHOSPASM 
IN GUINEA PIGS 
The  method was followed in which  bronchospasm  was  induced  in  guinea  pigs  
by exposing  them  to histamine  aerosol  under standardized conditions. The efficacy of 
the test drug was evaluated by estimating the degree of protection imparted against 
histamine induced bronchospasm.   
Experimental bronchospasm: 
Bronchospasm was induced by exposing the animals to histamine acid phosphate 
0.25% and  acetylcholine chloride 10% under a constant pressure 40 mm/Hg from the 
inbuilt nebuliser of the histamine chamber 
The  animals  were placed inside the “Histamine exposition chamber” and a finely 
atomized mist of 0.25% solution of histamine acid phosphate was blown into the chamber 
through a nebulizer under 40mm Hg pressure.  
The preconvulsive time (PCT) was determined from the time of exposure to the 
onset of dyspneoa leading to the appearance of convulsions which is known as 
preconvulsive dyspnoea (PCD). As soon as the PCD were noted, the animals were 
removed from the chamber and placed in fresh air. 
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The sharp fall of animal due to asphyxia was taken as the end-point. The time 
period from the onset of the exposure to the sharp fall of the animal on its  side  was  
designated  as  the  “exposition time”.   
The animals  which  did  not  develop  the  typical  features  of asphyxia like 
restlessness,  irritation of skin and  mucous membrane  (sneezing), scratching  of ear,  
deep slow  and labored respiration, drawing of the abdominal wall, to and fro  movement 
of  the head,  appearance  of  cyanosis,  air hunger  (animal  raising  its  head  in  intense  
inspiratory effort) even after more than three minutes of exposure to histamine  were  
considered  resistant  or  completely protected  (C.P)  and  such  animals  were  excluded  
from study.  
Two and half hour after the initial exposure to histamine aerosol, single dose of 
the drug/ vehicle was administered to various groups as per the following schedule:  
Grouping and drug treatment: 
Group  I:  Control  group,  received  Normal  Saline 1ml/100gm.  
Group  II:  Treated  with  Chlorpheniramine  maleate 1.6mg/kg (standard drug).  
Group III and IV: Treated with TM 400mg/kg and 800mg/kg respectively 
All the drugs/ vehicle was administered orally. The doses of the test drug were 
selected after observing the response to it in  pilot  studies  as  well  as  after  referring  to  
the literature. The dose of  Chlorpheniramine  maleate were chosen after considering their 
recommended clinical doses.  
These animals were subjected to histamine and acetylcholine challenge one and a 
half hours after receiving the drug and the PCT was noted. Animals which withstood 
exposure to histamine or acetylcholine aerosol for 15 minutes were considered to be 
completely protected. 
Data analysis was done by one-way analysis of variance (ANOVA) followed by 
Dunnett's multiple comparisons test. Probability values of 0.05 or less were considered 
statistically significant.
[82,83,84] 
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5. RESULTS AND DISCUSSION 
            The medicine Thirijadhathi mathirai had been subjected to various studies and 
standardization to establish the works of Siddhars to be true. Literary collections, 
Physicochemical Studies, Elemental analysis, Bio-chemical analysis, Toxicity studies, 
Pharmacological studies are done to prove the Anti-tuberculosis activity of 
Thirijadhathi  mathirai. Literary collections about the drug from various text books 
give hope about its activity. The studies strongly supported the fact through these 
results. They are discussed below: 
The extensive review on botanical aspect gave information about the 
Microscopical, Macroscopical, medicinal uses, Chemical constituents and the 
importance of the herbs in detail. Most of the herbs included in the formulation are 
Anti-bacterial, Anti-microbial, Expectorant, Anti pyretic and Tonic. 
 Cinnamomum zeylanicum posses anti-microbial activity which is useful in 
the treatment of Mycobacterium tuberculosis. The major compound cinnamaldehyde 
posses strong antimicrobial activity.
[86]
 
 Cinnamomum tamala is considered as potential antimicrobial agent and 
posses anti-bacterial activity.
[87]
  
Eletteria cardamomum also cures asthma, bronchitis,  cold and cough. It also 
has strong anti-bacterial activity.
[88]
  
Thipilli is indicated for pulmonary tuberculosis, chronic cough, asthma for its 
bronchodilator activity. Piperine present in this will exhibits Anti-bacterial activity, 
has significant activity against multi drug resistant strains of mycobacterium spp.
 [89] 
 
  Karkandu has antibiotic action.
[90] 
Dried dhiratchai is used to treat anaemia; it can be given for the patients with 
fever, cough and tuberculosis.
 
 Adhimathuram has tonic and expectorant action. It will melt phlegm due to 
Iyam. Exhibits activity against MDR isolates of H37Rv Mycobacterium tuberculosis 
strain.
[91]
 
 Karchurkai posses antimicrobial activity. It also has immunostimulant activity 
which enhances the immune system. 
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The pharmacological aspect of the drug says about their mode of action which 
was used from ancient times. The current pharmacological methods available for 
carrying out the Anti-tuberculosis activity were explained clearly and the suitable In-
vitro models for carrying out the activities were discussed. And explains, whether the 
drug effectively inhibits the proliferation of Mycobacterium tuberculosis. 
The Pharmaceutical review explained the preparation of Mathirai in detail 
including the purification of raw drugs, methods of manufacturing and the Siddha 
parameters for the standardization of Mathirai. 
The standardization of the drugs was achieved through various procedures like 
analyzing the organoleptic characters, physico-chemical characters, elements present 
in the drug and the results and discussion of standardization parameters is described 
below. 
Results of physical characterisation: 
Table: 2 Organoleptic Character 
S.No Parameters Results 
1 Colour Brown 
2 Odour Characteristic odour 
3 State of matter Semi Solid 
4 Consistency Soft 
5 Shape Spherical 
 
Table: 3 Results of Physico-chemical analysis 
S.NO Parameters Results 
1 pH 4.69 
2 Total ash 2.84% 
3 Acid insoluble ash 0.49% 
4 Water soluble ash 1.42% 
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DISCUSSION: 
pH value  
 The  pH of TM  is 4.69. It is acidic in nature. For drug absorption to 
occur, a drug must cross biological barriers. Drugs that are weak acids will pick up a 
proton when placed in an acidic environment and will, thus, be un-ionized. 
 Drugs that are un-ionized will be better able to diffuse through a lipid 
cellular membrane, cross a biologic barrier and enter the bloodstream. 
 A drug that is a weak acid will be absorbed primarily in the acidic 
environment. Eventhough the stomach is acidic, it is not well-suited for drug 
absorption, even for drugs that are weak acids due to its thick mucus layer and 
relatively small surface area. As a result, acidic drugs are most to be absorbed in the 
acidic areas of the proximal duodenum.
[92] 
Total ash  
Total ash value will determine the amount of total inorganic content 
(ammonium, potassium, calcium, chloride, iron etc.) present in the drug after ignition 
is measured through it. 
The total ash value of TM is 2.84%, this indicates that the drug has less 
contamination and adulteration. 
Acid insoluble ash 
The acid insoluble ash value of the drug denotes the amount of siliceous 
matter (dust, sand etc,) present in that drug. 
The quality of the drug is better if the acid insoluble ash value is low. 
Here, acid insoluble ash value of TM is 0.49%. Hence, it represents the 
superior quality of the TM. 
5 Water soluble extraction 48.8% 
6 Acid soluble extraction 44% 
7 Loss on Drying at 105⁰C 8.65% 
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Water soluble ash 
Water soluble ash is a part of total ash value, which denotes the diffusion 
capacity of the drug. 
Here, the water soluble ash value of TM is 1.42%, which represents easy 
facilitation of diffusion and osmosis mechanism. 
Disintegration time 
According to Ayush guidelines, the disintegration time does not exist more 
than 45 min. 
The disintegration time of TM is 22 min. 
This implies a reasonable disintegration time, thereby a better absorbability 
and solubility is achieved. 
Loss on Drying (LOD) 
It indicates the amount of volatile substance and moisture present in the drug. 
The loss on drying percentage of TM is 8.65. This indicates the stability and 
shelf life of the drug. 
 
PHYTOCHEMICAL ANALYSIS: 
Table: 4 phytochemical screening tests 
 
S.No. 
 
Phytochemicals 
 
Test Name 
 
H2O Extract 
 
1 Alkaloids Dragendroff’s Test +ve 
3 Glycoside Modified Borntrager’s Test +ve 
4 Saponin Froth Test +ve 
5 Phenols Ferric Chloride Test +ve 
7 Flavonoids Alkaline Reagent Test +ve 
8 Proteins Xanthoprotein Test -ve 
10 Diterpenes Copper Acetate Test +ve 
11 Gum & Mucilage Extract + Alcohol +ve 
 
+ve/-ve present or absent if component tested 
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Fig. 17 Phytochemical analysis 
DISCUSSION: 
From the primary phytochemical screening tests of Thirijadhathi mathirai shows 
Alkaloids, Glycosides, Saponnins, Flavanoids, Phytosterol, Phenol, Diterpenes, Gum 
and mucilage. 
Alkaloids
 [93] 
 Alkaloids have a wide range of pharmacological activity like Anti-
bacterial. 
 These alkaloids will enhance the action of TM. 
 Alkaloids possess antispasmodic, analgesic, bactericidal effects. 
 Alkaloids are the active principles producing many essential effects in 
protecting the body. 
Glycosides
 
 Many plants store chemicals in the form of inactive glycosides, such plant 
glycosides are used as medications. 
 Inhibitory effect against Mycobacterium tuberculosis showed the 
conjugates of glycosides. The anti-tubercular activity is higher than drug 
Pyrizamide but lower than the drug Isoniazid.
[94]
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Tannins 
 Tannins exhibits anti- Mycobacterial activity by inhibiting the total 
growth and also of patients strain, which was fully sensitive to the 
standard anti tuberculosis drug.
[95]
 
 Herbal preparation containing tannins are used for bronchitis and many 
others. 
 Tannins are considered as anti-oxidants which prevents the onset of 
degenerative diseases.
[96]
 
Phenols
 
 Various bioactivities of phenolic compounds are responsible for their 
chemopreventive properties ( anti-oxidant, anti-inflammatory effects 
etc,)
[97] 
 It will reduce the inflammation in tuberculosis. 
 Phenols could be a source of natural anti- tuberculosis agents. 
Diterpenes 
 Suppress the inflammatory process. 
 Anti-oxidant and Anti-microbial activity. 
 Anti-bacterial agents will destroy the bacterial growth  and proliferation of 
bacteria (Mycobacterium tuberculosis).
[98]
 
 The substance inhibited 99% the growth of Mycobacterium tuberculosis 
H37Rv, that oleanolic acid has a synergistic effect when combined with 
Isoniazid, Rifampicin or Ethambutol.
[99]
 
Proteins
 
 Body uses protein to build and repair tissues, which are degenerated by 
the tubercular bacilli.
[100]
 
 Substituted aminopyrimidine protein kinase B (PknB) inhibitors show 
activity against Mycobacterium tuberculosis.
[101]
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TLC/ HPTLC finger print studies  
Stationary Phase - Silica Gel 60 F254 
Mobile Phase - Toluene: Ethyl Acetate: Formic Acid (5: 2: 0.1 v/v/v) 
   
  = 254 nm    = 366 nm    = 575 nm (Derivatized) 
 
Fig:18 HPTLC finger print 
 
 
 
Table: 5 TLC photo documentation of chloroform extract of Thirijadhathi Mathirai 
Colour Rf  value(s) Colour Rf  value(s) Colour Rf value(s) 
Green 0.21 Magenta 0.21 Light Blue 0.21 
Green 0.22 Blue 0.22 Brown 0.22 
Green 0.34 Light Blue 0.34 Blue 0.34 
Green 0.40 Light Blue 0.40 Light Blue 0.42 
Green 0.46 Greenish Blue 0.60 Violet 0.52 
Green 0.78   Light Blue 0.60 
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Fig: 19 Derivatized plate HPTLC Chromatogram @ 575 nm 
 
Table: 6 Peak Table @ 575 nm 
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DISCUSSION: 
 A qualitative fingerprinting of Thirijadhathi mathirai has been performed by 
HPTLC method, which provides qualitative insights into the bioactive Constituents 
present in the drug. HPTLC shows separation of components present in the 
Chloroform extract of Thirijadhathi mathirai. The method may be applied to identify 
the Thirijadhathi Mathirai from other manufacturing process.  
The present study revealed that Thirijadhathi mathirai showed best results in 
Toluene: Ethyl Acetate: Formic acid: 5:2:1 solvent system. After scanning and 
visualizing the plates in absorbance mode at 254nm, 366 nm and 575 nm and visible 
light range, best results were shown at 575 nm.  
TLC plate showed different colour phyto constituents of chloroform extract of 
Thirijadhathi mathirai. The bands revealed presence of six greenish, five light blue, 
two blue, one greenish blue, one magenta, one brown and one violet band showing the 
presence of steroids, terpenoids, alkaloids, flavanoids, tannins, lignans and saponins. 
The results from HPTLC finger print scanned at wavelength 575 nm for 
chloroform extract of Thirijadhathi mathirai. There are ten polyvalent phyto 
constituents and corresponding ascending order of Rf values start from 0.06 to 0.74 in 
which highest concentrations of the phyto constituents was found to be 29.05% and 
14.24 % with its corresponding Rf value were found to be 0.30 and 0.54 respectively. 
 
BIO CHEMICAL ANALYSIS: 
Table : 7 Results of acid and basic radical studies 
S.No Parameter Observation Result 
1. Test for Potassium Formation of yellow colour 
precipitate 
Positive 
 
2. Test for Ammonium Appearance of brown colour Positive 
 
3. Test for Phosphate Appearance of  yellow precipitate Positive 
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 From the acid and basic radicals studies of Thirijadhathi mathirai presents the 
following chemicals:   Potassium, Ammonium and phosphate. 
Potassium:
 
 Clavulanate potassium demonstrates synergestic anti-bacterial activity.[103] 
Ammonium :
[104]
 
 Ammonium is essential in the body as a building block for making proteins 
and other complex molecules. 
 It is essential for much biological process and serves as a precursor for amino 
acid and nucleotide synthesis. 
Phosphate: 
[105] 
 Phosphate is an essential mineral primarily used for growth and repair of body 
cells and tissues. 
 It is also required for a variety of biochemical processes including energy 
production and pH regulation. 
 It is a component of DNA and RNA molecules. 
 Hemoglobin, the important oxygen carrying protein in the bloodstream, also 
depends upon phosphorus contained in its structure for proper function. 
 In TB patient, it will produce energy to the patient, regulate the pH and repairs 
the host cell. 
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Table: 8 ANTI-MICROBIAL ACTIVITY: 
BACTERIAL LOAD: 
                                                    GRAM POSITIVE 
Table: 8.1 Organism: Staphylococcus aureus 
Sample Concentration 
(μg/mL) 
Zone of inhibition       
(mm) 
Thirijadhari Mathirai 
(TM) 
Streptomycin (100µg) 26 
250 17 
500 21  
1000 23                  
14mm- low sensitive; 15mm- moderate; 16mm- highly sensitive 
                                                   GRAM NEGATIVE 
Table: 8.2 Organism: Escherchia coli 
Sample Concentration 
(μg/mL) 
Zone of inhibition       
(mm) 
Thirijadhari Mathirai 
(TM) 
Streptomycin (100µg) 26 
250 14 
500 20  
1000 22 
14mm- low sensitive; 15mm- moderate; 16mm- highly sensitive 
                                   Table: 8.3 Organism: Klebsiella pneumoniae 
Sample Concentration 
(μg/mL) 
Zone of inhibition       
(mm) 
Thirijadhari Mathirai 
(TM) 
Streptomycin (100µg) 25 
250 15 
500 19 
1000 23 
14mm- low sensitive; 15mm- moderate; 16mm- highly sensitive 
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                                  Table: 8.4 Organism: Pseudomonas aeroginosa 
Sample Concentration 
(μg/mL) 
Zone of inhibition       
(mm) 
Thirijadhari Mathirai 
(TM) 
Streptomycin (100µg) 30 
250 17 
500 24 
1000 26 
14mm- low sensitive; 15mm- moderate; 16mm- highly sensitive 
                                           Table: 8.5 Organism: Aspergillus niger 
Sample Concentration 
(μg/mL) 
Zone of inhibition       
(mm) 
Thirijadhari Mathirai 
(TM) 
Clotrimazole(100µg)  37 
250 24 
500 26 
1000 32 
14mm- low sensitive; 15mm- moderate; 16mm- highly sensitive 
Inference:  
1. Escherchia coli   - Highly sensitive in 500(μg/mL) 
2. Klebsiella pneumoniae   - Highly sensitive in 500 (μg/mL) 
3. Pseudomonas aeruginosa   - Highly sensitive in 250(μg/mL) 
4. Staphylococcus aureus   - Highly sensitive in 250 (μg/mL)  
5. Aspergillus niger    - Highly sensitive in 250 (μg/mL) 
DISCUSSION: 
The development of resistance against the presently available antibiotics arises 
the necessity of rediscovery of new anti-bacterial and anti-fungal agents in traditional 
systems of medicine. Different dosages of test drug against the microbes in 
antimicrobial activity of TM was compared with Standard drug Streptomycin and 
Clotrimazole (100μg)/ml disc for the following pathogens, they are Escherchia coli, 
Pseudomonas aeruginosa, Klebsiella pneumoniae, Staphylococcus aureus, 
Aspergillus niger. The results represents TM potentially inhibit the growth of all 
above organism in 250μl, 500μl and 1000μl / disc. 14 mm – Low sensitive, 15 mm – 
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Moderate, above 16 mm – Highly sensitive. The findings reveal that the Siddha drugs 
TM have anti-microbial potency against bacterial and fungal pathogens which is used 
in the treatment of diseases.  
INSTRUMENTAL ANALYSIS: 
Fig. 20 FTIR (FOURIER TRANSFORM INFRARED SPECTROSCOPY) 
 
 
 
 
 
 
 
 
 
 
 
 
Table: 9 FTIR interpretation of Thirijadhathi mathirai 
Absorption 
peak cm-1 
Stretch Functional Group 
3393 
O-H(stretch, H- Bonded), N-H 
stretch, 
Amide and alcohols 
2926 C-H stretch, O-H stretch Alkenes and Acid 
2168 -C ≡C- stretch Alkynes 
1650 C=C stretch, C=O stretch Alkenes, Amide 
1425 -C-H bending, C=C stretch Alkanes, Aromatic 
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TM 
3393 
2926 
2168 
1650 1425 
1364 
1029 
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782 
766 
575 
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DISCUSSION: 
In TM there will be Amide, Alcohol, Alkanes, Alkenes, Alkyl Halide and 
Nitro group. 
Amide
 
Some antibiotics are made with amides (E.g Ampicilline) to treat bacterial 
infection.
 [106] 
Alcohol 
Ethanol killed the tubercle bacilli in sputum or water suspension within 15 
seconds.
 [107] 
SEM (SCANNING ELECTRON MICROSCOPE)
 
 
 
 
 
 
 
                                                    Fig: 21 SEM image  
1364 
-C-H bending, C-F stretch, N-O 
stretch 
Alkanes, Alkyl Halide, 
Nitro group 
1029 C-F stretch, C-O stretch Alkyl Halide, Ether 
924 =C-H Alkenes 
782 =C-H bending, C-Cl Stretch Alkenes, Alkyl Halide 
766 =C-H bending, C-Cl Stretch Alkenes, Alkyl Halide 
575 C-Br Stretch Alkyl Halide 
89.7 nm 
97.8 nm 
109.2 nm 
138 nm 
96.9 nm 
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      Fig: 22 SEM image 
DISCUSSION: 
Micro medicine has its benefit in the treatment for many chronic diseases. The 
advantage of the micro particle is its smaller size which enhances the solubility, 
bioavailability of the drug and avoids macrophage clearance. It reduces possibly of 
side effects. 
Particles ranging from 1 to 1000 nm are called micro particles.  SEM analysis 
of the drug Thirijadhathi  mathirai revealed the presence of micro particles of size 2 
to 4 microns.  The particles of size micron show that the drug may easily enter the 
cells at the molecular level to treat the disease rapidly and increase the therapeutic 
effect. 
ICP-OES RESULTS OF THIRIJADHATHI MATHIRAI 
Table: 10 ICP-OES interpretation of Thirijadhathi mathirai 
S. no Elements Wavelength Detected levels 
1. Arsenic (As) 188.979 BDL 
2. Calcium (Ca) 315.807 21.180 mg/L 
3. Cadmium (Cd) 228.802 BDL 
4. Iron (Fe) 238.204 01.334 mg/L 
5. Mercury (Hg) 253.652 BDL 
6. Potassium (K) 766.491 13.571 mg/L 
7. Sodium (Na) 589.592 24.180mg/L 
8. Nickel (Ni) 231.604 BDL 
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9. Lead (Pb) 220.353 BDL 
10. Phosphorus (P) 213.617 96.357mg/L 
11. Aluminium (Al) 396.152 BDL 
12. Copper (Cu) 327.393 BDL 
13. Magnesium (Mg) 285.213 01.774mg/L 
14. Zinc (Zn) 206.200 01.256mg/L 
 
BDL:Below Detectable Limit 
1% = 10000ppm, 
1ppm = 1/1000000 or 1ppm = 0.0001% 
The toxic metals and the permissible limits 
Heavy metals  WHO & FDA limits 
Arsenic (As)      10ppm 
Mercury (Hg)      1ppm 
Lead (Pb)      10ppm 
Cadmium (Cd)     0.3ppm 
 
DISCUSSION: 
The result indicate that the formulation is extremely safe as it contains heavy 
metals within specified limits. 
ICP-OES reveals the  concentration of many minerals present in the drug. It 
also  has physiologically important minerals like Calcium, Iron, Potassium, Sodium, 
Phosphorus, Magnesium and Zinc. Thirijadhathi mathirai, the heavy metals like 
Arsenic, Cadmium, Lead and trace element like Nickel were below detectable level. 
This reveals the safety of the drug so that it can be used in long terms without side 
effects. 
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TOXICOLOGICAL STUDIES 
Acute oral toxicity in rats 
Dose finding experiment and its behavioural Signs of Toxicity for Thirijadhathi 
mathirai 
Table: 11 Observation of acute toxicity study 
SL              Group 
            CONTROL 
Observation SL Group 
TEST GROUP 
Observation 
1 Body weight Normal 1 Body weight Normally increased 
 
2 Assessments of posture Normal 2 Assessments of 
posture 
Normal 
3 Signs of Convulsion 
Limb paralysis 
Normal 3 Signs of Convulsion 
Limb paralysis 
Absence of sign (-) 
4 Body tone Normal 4 Body tone Normal 
5 Lacrimation Normal 5 Lacrimation Normal 
6 Salivation Normal 6 Salivation Normal 
7 Change in skin color No significant 
color change 
7 Change in skin color No significant color 
change 
8 Piloerection Normal 8 Piloerection Normal 
9 Defecation Normal 
 
9 Defecation Normal 
 
10 Sensitivity response Normal 10 Sensitivity response Normal 
11 Locomotion Normal 11 Locomotion Normal  
12 Muscle gripness Normal 12 Muscle gripness Normal 
13 Rearing Mild 13 Rearing Mild 
14 Urination Normal 14 Urination Normal 
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Table: 12 Dose finding experiment and its behavioural Signs of Toxicity for 
Thirijadhathi mathirai 
1. Alertness 2. Aggressiveness 3. Pile erection 4. Grooming   5.Gripping   6.Touch 
Response 7. Decreased Motor Activity   8.Tremors 9. Convulsions 10. Muscle Spasm 
11. Catatonia 12.Musclerelaxant 13.Hypnosis 14.Analgesia 15.Lacrimation 16. 
Exophthalmos 17. Diarrhoea  18. Writhing   19. Respiration   20.  Mortality 
Table: 13  Observation of Body weight  
 
 
 
 
 
N.S- Not Significant, **(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D 
(One-way ANOVA followed by Dunnett’s test) 
Table: 14 Water intake (ml/day) of Wistar albino rats group exposed to 
Thirijadhathi mathirai: 
                       
DOSE 
 
DAYS 
1 7 14 
CONTROL 58 ± 1.02 58±9.20 59.4±1.04 
HIGH DOSE 59.4±2.20 59.8±3.40       59.9±6.24 
P value (p)* NS NS NS 
N.S- Not Significant, **(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D 
(One-way ANOVA followed by Dunnett’s test) 
Dose 
mg/kg 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
2000m
g/kg 
+ - - - - + - - - - - - - - - - - - + - 
DOSE 
 
DAYS 
1 7 14 
CONTROL 320.2±42.30  322.4 ± 60.10 323.6 ±52.10 
HIGH DOSE 302.4± 1.21 314 ± 2.04 321.2 ± 2.10 
P value (p)* NS NS NS 
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Table 15: Food intake (gm/day) of Wistar albino rats group exposed to 
Thirijadhathi mathirai      
 
DOSE 
 
DAYS 
1 7 14 
CONTROL 61.04±2.62 62.2±4.76 64.3±6.26 
High DOSE 69.4±4.23 70.4±6.22 76.6±4.18 
N.S- Not Significant, **(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D 
(One-way ANOVA followed by Dunnett’s test) 
DISCUSSION: 
In the acute toxicity study, the rats were treated with different concentration of 
Thirijadhathi  mathirai from the range of 5mg/kg to 2000mg/kg which did not 
produce signs of toxicity, behavioural changes and mortality in the test groups as 
compared to the controls when observed during 14 days of the acute toxicity 
experimental period. 
These results showed that a single oral dose of the extract showed no mortality 
of these rats even under higher dosage levels indicating the high margin of safety of 
this extract. 
In acute toxicity test the Thirijadhathi mathirai was found to be nontoxic at 
the dose level of 2000mg/ kg body weight. 
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SUB-ACUTE ORAL TOXICITY 28 DAYS REPEATED DOSE STUDY IN 
RATS 
Table: 16 Body weight (g) changes of rats exposed to Thirijadhathi mathirai 
Dose 
(mg/kg/day) 
Days 
0 7 14 21 28 
Contro
l 
120.59±0.92 122.79±0.87 123.52±1.18 127.24±1.12 131.25±1.05 
100 
125.92±0.63 128.14±1.01 131.19±1.30 133.82±1.18 138.62±1.27 
200 126.49±3.6 128.66±3.2 130.42±4.6
7 
134.12±6.5
2 
135.32±3.08 
400 
128.53±3.83 135.17±1.34 139.30±1.35 141.34±1.58 146.55±1.50 
Values are expressed as mean ±S.E.M.   N=10 
Table 17: Water intake (ml/day) of Wistar albino rats group exposed to 
Thirijadhathi Mathirai 
 
 DOSE 
 
DAYS 
1 7 14 21 28 
CONTROL 60.1 ± 8.72      60±1.52 60.2±1.40 61±1.32 61.4±1.62 
LOW DOSE 65.1±1.21 65.6±4.22 66.6±1.02 65.2±2.06 66.4±1.20 
MID DOSE 62.1±1.02 62.3±1.21 62.1±2.62 63.4±4.32 63.4±1.64 
HIGH 
DOSE 
64.1±1.81 64.2±1.32 64.4±1.14 64.6±1.62 65.8±2.02 
P value (p)* NS NS NS NS NS 
 
N.S- Not Significant, **(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D (One 
way ANOVA followed by Dunnett’s test) 
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Table 18: Food intake (gm/day) of Wistar albino rats group exposed to 
Thirijadhathi Mathirai 
 
 N.S- Not Significant, **(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test 
 
Table: 19 Effect of Thirijadhathi mathirai on Haematological parameters in rats 
Parameter Control 100 mg/kg 200 mg/kg 400 mg/kg 
RBC 
(x 10
6
/mm
3
) 
7.51 ± 0.16 6.46±0.32 7.4±1.46 7.32±0.9 
PCV (%) 48.2 ± 1.3 43.3±2.12 48.2±1.62 47.6±3.37 
Hb (%) 15.6 ± 0.19 14.8±2.46 14.9±3.6 14.56±1.46 
WBC 
(x 10
3
/mm
3
) 
10.12 ± 1.2 11.5±1.6 11.7±2.1 12.8±4.16 
Neutrophils (%) 22 ± 4 26.46±5.3 34.2±4.2 28.7±2.78 
Mononuclear cells 
(%) 
76 ± 2 72.4±3.8 60.4±2.3** 70.3±4.2 
Eosinophils (%) 2.4 ± 0.6 2.2±0.28 1.6±0.06 1.8±0.07 
Platelets (x 10
3
/mm
3
) 423.2 ± 48.8 424.56±16.4 446.14±32.6 414.8±28.44 
       
**P<0.01,***P<0.001 vs control;  N=10 
DOSE 
 
DAYS 
1 7 14 21 28 
CONTROL 34±4.14 34.2±6.12 34.3±2.18 34.2±1.14 34±5.62 
LOW DOSE 36.3±1.64 36.3±1.51 36.2±1.51 36.5±1.62 36.5±1.22 
MID DOSE 34.1±2.12 34.2±3.50 34.2±2.14 34.2±2.16 35.2±1.64 
HIGH DOSE 32.4±1.62 32.1±1.64 32.6±2.36 32.6±1.20 36.4±2.32 
P value (p)* NS NS NS NS NS 
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Table: 20 Effect of Thirijadhathi mathirai on Biochemical parameters in rats 
Parameters Control 100 mg/kg 200 mg/kg 400 mg/kg 
Protein (g/dl) 8.62 ± 1.3 6.9±0.94 8.6±0.56 7.18±0.78 
Albumin (g/dl) 4.8 ± 0.6 4.4±0.34 3.7±0.54 4.22±0.76 
BUN (mg/dl) 19.2 ± 1.2 21.2±1.4 24.81±4.6 22.7±2.42 
Urea (mg/dl) 64.24 ± 3.11 66.42±5.6 68.3±4.2 66.53±4.4 
Creatinine (mg/dl) 0.82 ± 0.16 0.46±0.02* 0.72±0.06 0.83±0.08 
Total Cholesterol 
( mg/dl) 
91.24 ± 1.35 96.5±7.9 117.14±8.2* 103.7±6.24 
Triglycerides 
( mg/dl) 
50.15 ± 3.21 59.3±4.4 69.14±3.12*
* 
70.18±4.43*
* 
Glucose (mg/dl) 110.16 ± 
8.62 
97.67±5.18 117.8±5.26 83.94±7.16* 
Total Bilirubin 
(mg/dl) 
0.205 ± 0.04 0.242±0.06 0.533±0.07*
* 
0.753±0.04 
SGOT (U/L) 73 ± 2.4 53.2±4.4* 66.8±2.84 72.19±7.38 
SGPT(U/L) 28.4 ± 1.2 33.6±3.46 59.7±6.69** 71.6±6.52** 
Alkaline 
phosphatase(U/L) 
102.4 ± 3.6 96.7±6.6 103.6±4.9 86.44±3.23 
Sodium (mEq/L) 138.12 ± 
3.14 
112.7±2.6 136.42±7.32 119.44±5.82
* 
Potassium 
(mEq/L) 
7.2 ± 1.34 3.26±0.18 5.42±0.28 4.63±0.09* 
 
NS- Not Significant, **(p >0.01), * (p >0.05), n = 10 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test 
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DISCUSSION: 
The dose selected for the sub-acute toxicity study was 100mg, 200mg/kg and 
400mg/kg of Thirijadhathi mathirai. 
All the animals were free of intoxicating signs throughout the dosing period of 
28 days. No physical changes were observed throughout the dosing period. No 
mortality was observed during the whole experiment. No abnormal deviations were 
observed. No significant changes were observed in the values of different parameters 
studied when compared with controls and values obtained were within normal 
biological and laboratory limits. 
There was no significant changes were observed in haemoglobin (Hb), red 
blood cell (RBC), white blood cell (WBC), packed cell volume (PCV), Erythrocyte 
sedimentation rate (ESR) in all the treated groups as compared to respective control 
groups. 
DISCUSSION ON HISTOPATHOLOGY: 
Histopathology studies were carried out on liver, kidney and spleen and 
recorded. Blood samples for haematological and blood chemical analyses were taken 
from common carotid artery. 
All rats were sacrificed after the blood collection. The internal organs and 
some tissues were observed for gross lesions. All tissues were preserved in 10% 
neutral buffered formaldehyde solution for histopathological examination. 
From the acute and sub-acute toxicity studies the drug produced some 
significant changes, but the values were found within normal limits. So the drug 
Thirijadhathi mathirai was nontoxic and safe. 
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FIG. 23 HISTOPATHOLOGY SLIDES: 
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           NORMAL      HIGH DOSE 
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PHARMACOLOGICAL ACTIVITY 
ANTI-TUBERCULOSIS ACTIVITY: 
Table: 21 Anti- tuberculosis activity of Thirijadhathi mathirai 
 
S.NO. Compound Name % Reduction in RLU 
250µg/ml 500µg/ml Rifampicin 
2µg/ml 
1. Mycobacterium 
tuberculosis H37Rv   
52.15 56.98 93.66 
 
  
 
       Chart 1: Anti tuberculosis activity  
DISCUSSION: 
When the TM was dissolve in DMSO, it is subjected into Luciferase reporter 
phage assay for anti-Mycobacterial activity study. The anti-Mycobacterial activity of 
TM is indicated by fifty five and above fifty five percent reductions in relative light 
units (RLU) in the presence of compound in comparison with compound free control. 
TM indicates anti- tuberculosis activity in Mycobacterium tuberculosis H37Rv.  From 
these above results we can conclude this Siddha herbal formulation TM validated as a 
valuable drug for the treatment of Tuberculosis. 
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BRONCHODILATOR ACTIVITY: 
TABLE: 22 Bronchodilator activity of Thirijadhathi mathirai 
 
Serial 
No 
Group Onset  of 
Convulsion  in sec. 
% protection 
 
1 
 
Control 
 
 
91.45±0.093 
 
-- 
 
2 
 
Standard  
Salbutamol 2 mg/kg 
 
1032.0±4.5* 
 
92.4 
 
3 
 
TM (200mg/kg) 
 
254.4±1.96** 
 
66.52  
 
4 
 
TM (400mg/kg) 
 
406.2.±1.57** 
 
79.12  
 
Values are mean ±S.E.M. (n=6) *p<0.01, **p<0.001compared with the 
control animals 
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Chart 2: Bronchodilator activity 
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DISCUSSION: 
From the above results, we can confirm that the TM possess bronchodilator 
activity nearer to fifty percentages when compared with Salbutamol as a standard 
drug. 
 
ANTI-HISTAMINE ACTIVITY: 
Table: 23 Anti-histamine effect of Thirijadhathi  mathirai 
 
S.no 
 
Treatment Group 
Mean exposition time insec 
After histamine exposure 
Mean exposition time in 
sec after acetylcholine 
exposure 
Before 
treatment 
After 
treatment 
Before 
treatment 
After 
treatment 
1 Normal 105.21±1.52 104.33±1.26 51.33±1.09 52.12±1.03 
2 Chlorpheniramine 102.31±2.03 182.02±1.09 52.53±1.22 87.57±2.04 
3 TM 200mg/kg 104.53±1.06 119.04±2.01 53.10±1.20 57.21±1.51 
4 TM 400mg/kg 102.65±2.06 148.59±2.07 52.20±2.08 58.01±1.08 
 
EXPOSITION TIME AFTER HISTAMINE AND ACETYLCHOLINE: 
 
Chart 3: Anti-histamine activity 
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DISCUSSION 
Mediators like histamine, serotonin and acetylcholine are implicated in various 
ways in the pathogenesis of Asthma. Histamine is the most implicated mediator in 
broncho constriction that accompanies asthma although the role of serotonin in 
asthma is uncertain. Thirijadhathi mathirai inhibited the histamine induced 
bronchospasm (vascular permeability) in rats, when compared with Chlorpheniramine 
as standard. Here, Thirijadhathi mathirai possess the Anti- histamine activity. 
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6. CONCLUSION 
 The drug Thirijadhathi mathirai was selected from “Anubava vaithiya 
devaragasiyam” to validate the safety and its efficacy in treating for 
tuberculosis. 
 The ingredients of the drug was identified and authenticated by Gunapadam 
experts. Then drug was prepared as per the literature and subjected to various 
studies. 
 When it was subjected into physico chemical, organoleptic character it was 
fulfils all the parameters of mathirai according to AYUSH guidelines. 
 In the phytochemical, biochemical analysis, HPTLC showed the presence of 
active ingredients responsible for its activity. Phyto chemical showed the 
presence of Alkaloids, Glycosides, Tannins, Phytosterol, Phenol, Triterpenes 
and Proteins. Biochemical analysis showed the presence of Potassium, 
Ammonium and phosphate. Thus, from those constituents it has a synergistic 
effect in acting against the disease. 
 In instrumental analysis, FT-IR showed the peak values of functional groups 
present in the drug. SEM showed the particle size. And ICP-OES showed the 
presence of Calcium, Iron, Potassium, Sodium and Phosphorus and absence of 
cadmium, lead arsenic and mercury in the permissible limits. 
 Toxicity studies done according to OECD guidelines showed the acute and 
repeated oral toxicity of the drug. The haematological and biochemical 
parameters showed slight various between 100, 200 and 400mg but within the 
limits when compared to control. The body weight of the animals has slight 
change (increased in body weight). Thus, it will establish the safety and 
potency of the drug when administrated for long time. 
 Thirijadhathi mathirai could be conformed as no-observed-adverse effect 
level (NOAEL) drug as it acts harmless under normal usage and to be of no 
toxicological concern. 
 Pharmacological studies was done In-vitro model for Anti-Mycobacterial 
activity and in animal model for bronchodilator and Anti-histamine activity. 
 By using Luciferase reporter phage assay, the Anti-tuberculosis activity of TM 
had proved in mycobacterium tuberculosis H37Rv. 
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 Bronchodilator activity, showed 50% of activity when compared with control 
in animal models. 
 Anti-histamine activity done in vascular permeability test in rats models. The 
drug will attain above 50% of activity when compared with control. 
 Thus, by scrutinizing all the above results, it is concluded that Anti 
tuberculosis, Anti-histamine and bronchodilator activity of TM was 
scientifically validated. Hence, it is safe and potent drug.   
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8. SUMMARY 
 In Siddha text “Anubava vaidhya daeva ragasiyam” the drug “Thirijadhathi 
mathirai” was selected for preclinical study to establish relevant strong literature 
indication to Anti tuberculosis, Bronchodilator and Anti-histamine activity. 
 The collection of relevant literature evidences used in the preparation of 
Thirijadhathi mathirai for the ingredients, which claims support as Anti-
Mycobacterial agent. 
 The drug was subjected to various studies to prove its safety and efficacy.  
 Standardization by physico chemical, phytochemical analysis was done. 
Phytochemical analysis of the drug reveals the presence of alkaloids, tannins, 
glycosides and triterpenes which are responsible for Anti-Mycobacterial activity. 
 Instrumental analysis like FT-IR, SEM and ICP-OES are done. The finger 
print was engaged by using modern analytical technique like HPTLC. SEM analysis 
showed the sizes of the drug are nano and micro particle. ICP-OES showed the heavy 
metals are in BDL and or in permissible limits. 
 Toxicity of the drug was revealed in both acute and repeated oral toxicity 
studies, which proved the non-toxic and safety of the drug. 
 Pharmacological studies of the drug showed the Anti-tuberculosis activity by 
using Luciferase reporter phage assay has proved in both Mycobacterium tuberculosis 
H37Rv and clinical isolated S, H, R & E resistant. Hence, it can be concluded as a 
therapeutically effective drug in MDR-TB also. 
 The Bronchodilator and Anti-histamine activity of the drug Thirijadhathi 
mathirai was scientifically validated. 
 In conclusion, Thirijadhathi mathirai was evaluated to be non-toxic in the 
tested doses and suggested remarkable medicinal value in the treatment of 
tuberculosis. 
 The final discussion and conclusion analysed the dissertation. The most vital 
part of experiment of the findings is also discussed and thereafter it is implicate to 
future studies and future research if possible. 
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7. FUTURE SCOPE 
 In Luciferase reporter phage assay, the drug Thirijadhathi mathirai  has its 
own potency against Mycobacterium tuberculosis H37Rv which has been established 
in this study. 
 An incredible action of this drug value against these organisms has been 
revealed from this study. 
 This must be implicated in the future chronic toxicity studies, preclinical 
studies in animal model and multi-centre clinical studies, which are required to 
understand the exact molecular mechanism of action. So it could be used to treat 
tuberculosis worldwide. 
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